chunk_id large_string | cik large_string | ticker large_string | company_name large_string | sic_code large_string | accession large_string | form_type large_string | filed_at large_string | fiscal_year float64 | fiscal_period large_string | chunk_type large_string | heading large_string | pre_context large_string | text large_string | source_url large_string | facts_count int32 | scale_cue_in_text bool | sample_stratum large_string | facts list | non_target_spans list |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0204bc6c5ba31867024d8a53831d078c06915b6de3e5b4504dc99a90a1bbae1f | 0001516551 | SKYE | Skye Bioscience, Inc. | 2834 | 000151655122000022 | 10-Q | 2022-08-15 | 2,022 | Q2 | notes | Loss Per Common Share | 0.01 ) The following outstanding shares of common stock equivalents were excluded from the computation of diluted loss per share of common stock for the periods presented because including them would have been anti-dilutive: | |
| Three Months Ended June 30, (Unaudited) | Six Months Ended June 30, (Unaudited) |
| 2022 | 2021 | 2022 | 2021 |
Stock options | 37,755,000 | 21,850,000 | 37,755,000 | 21,850,000 |
Common shares underlying convertible debt | 5,570,932 | 5,213,498 | 5,570,932 | 5,213,498 |
Warrants | 136,187,225 | 50,213,334 | 136,18... | https://www.sec.gov/Archives/edgar/data/1516551/000151655122000022/skye-20220630.htm | 16 | true | 10-Q|notes|16-40 | [
{
"fact_id": "3eb51fd98246294e9678719d5b9450b872961b52122bc160f214bbf7e1daff14",
"concept": "us-gaap#AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"unit": "shares",
"period": "duration:2022-04-01..2022-06-30",
"value": "37755000",
"displayed_text": "37,755,000",
... | [
{
"span_text": "30,",
"start": 28,
"end": 31,
"class": "date"
},
{
"span_text": "30,",
"start": 68,
"end": 71,
"class": "date"
},
{
"span_text": "2022",
"start": 88,
"end": 92,
"class": "year"
},
{
"span_text": "2021",
"start": 95,
"end": 99,
... |
32d15ef96fad7b6065e7317cc67151eb727c35484b5f65d143d9d8319c628e80 | 0001516551 | SKYE | Skye Bioscience, Inc. | 2834 | 000151655122000022 | 10-Q | 2022-08-15 | 2,022 | Q2 | mda | General Trends and Outlook | drome, macular degeneration and diabetic retinopathy. Data we presented at the American Association of Pharmaceutical Scientists ("AAPS") meeting held in November 2017 revealed that an early ocular formulation of SBI-200 was able to penetrate multiple compartments of the eye, including reaching the retina and the optic... | The evolving COVID-19 pandemic has prompted governments and businesses to take unprecedented measures, such as restrictions on travel and business operations, temporary closures of business, quarantines, and shelter-in-place orders. The COVID-19 pandemic has significantly curtailed global economic activity and caused s... | https://www.sec.gov/Archives/edgar/data/1516551/000151655122000022/skye-20220630.htm | 0 | false | abstention|0 | [] | [
{
"span_text": "19",
"start": 19,
"end": 21,
"class": "untagged_amount"
},
{
"span_text": "19",
"start": 243,
"end": 245,
"class": "untagged_amount"
},
{
"span_text": "19",
"start": 396,
"end": 398,
"class": "untagged_amount"
},
{
"span_text": "1",
... |
35c7c6ae4641d006b65e9ffb23be620c7ac396168cb84e155e06d1681bdda369 | 0001516551 | SKYE | Skye Bioscience, Inc. | 2834 | 000151655122000022 | 10-Q | 2022-08-15 | 2,022 | Q2 | notes | Fair Value Measurements | es The Company’s operations are subject to a number of risks and uncertainties, including but not limited to, changes in the general economy, the size and growth of the potential markets for any of the Company’s product candidates, uncertainties related to the impact of COVID-19 (Note 1), risks related to operating pri... | Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (the “exit price”) in the principal or most advantageous market for the asset or liability in an orderly transaction between market partici... | https://www.sec.gov/Archives/edgar/data/1516551/000151655122000022/skye-20220630.htm | 0 | false | abstention|0 | [] | [
{
"span_text": "1",
"start": 671,
"end": 672,
"class": "note_ref"
},
{
"span_text": "2",
"start": 859,
"end": 860,
"class": "note_ref"
},
{
"span_text": "1",
"start": 898,
"end": 899,
"class": "note_ref"
},
{
"span_text": "3",
"start": 1174,
"e... |
3f59d94778eea08a0272be2c1ba3e1c52c47b10f7062697254e9ea6ce266af61 | 0001516551 | SKYE | Skye Bioscience, Inc. | 2834 | 000151655122000022 | 10-Q | 2022-08-15 | 2,022 | Q2 | notes | Liquidity and Going Concern | suffer in the event of continued business interruptions, supply chain issues, delayed clinical trials, production or a lack of laboratory resources due to the pandemic and other global conditions. It is possible that the Company may encounter other similar issues relating COVID-19 or the cyberattack that will need to ... | The Company has made adjustments to its operations designed to keep its employees safe and comply with federal, state and local guidelines. The extent to which COVID-19 may further impact the Company’s business, results of operations, financial condition and cash flows will depend on future developments, which are high... | https://www.sec.gov/Archives/edgar/data/1516551/000151655122000022/skye-20220630.htm | 0 | false | abstention|0 | [] | [
{
"span_text": "19",
"start": 166,
"end": 168,
"class": "date"
},
{
"span_text": "19,",
"start": 395,
"end": 398,
"class": "untagged_amount"
},
{
"span_text": "100",
"start": 683,
"end": 686,
"class": "untagged_amount"
},
{
"span_text": "19",
"star... |
688c003fac069c4fe55c2884ce1173fd6473083aca4ad629ca122ed9ce8274d9 | 0001516551 | SKYE | Skye Bioscience, Inc. | 2834 | 000151655122000022 | 10-Q | 2022-08-15 | 2,022 | Q2 | notes | Stock-Based Compensation Expense | ment activities, other expenses and equipment and laboratory supplies. Costs incurred for the rights to use licensed technologies in the research and development process, including licensing fees and milestone payments, are charged to research and development expense as incurred in situations where the Company has not ... | Stock-based compensation expense is estimated at the grant date based on the fair value of the award, and the fair value is recognized as expense ratably over the vesting period with forfeitures accounted for as they occur. Upon the exercise of stock option awards, the Company's policy is to issue new shares of its com... | https://www.sec.gov/Archives/edgar/data/1516551/000151655122000022/skye-20220630.htm | 0 | false | abstention|0 | [] | [
{
"span_text": "718",
"start": 1248,
"end": 1251,
"class": "note_ref"
},
{
"span_text": "718",
"start": 1294,
"end": 1297,
"class": "note_ref"
}
] |
8ada7c5418e0872976da5ea40bc4dc776029c978579ee7c4f6367f6295b601f3 | 0001516551 | SKYE | Skye Bioscience, Inc. | 2834 | 000151655122000022 | 10-Q | 2022-08-15 | 2,022 | Q2 | notes | Asset Acquisition | — 4,000,000 — Asset Acquisition | The Company evaluates acquisitions of assets and other similar transactions to assess whether or not the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine if substantially all of the fair value of the gross assets acquired is concentrated in ... | https://www.sec.gov/Archives/edgar/data/1516551/000151655122000022/skye-20220630.htm | 0 | false | abstention|0 | [] | [] |
0342ef757ebaf32b996f6dd646ead2b83f99eac55d6b7cde7a09fb502a150711 | 0000318833 | TISI | TEAM, INC. | 7600 | 000031883323000018 | 10-Q | 2023-05-11 | 2,023 | Q1 | table_context | (in thousands, except share and per share data) (part 2) | 1 Table of Contents PART I—FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS TEAM, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share data) | |
| March 31, 2023 | December 31, 2022 |
ASSETS | (unaudited) |
Current assets: |
Cash and cash equivalents | $ | 31,869 | $ | 58,075 |
Accounts receivable, net of allowance of $ 4,926 and $ 5,262 respectively
| 178,211 | 186,689 |
Inventory | 37,998 | 36,331 |
Income tax receivable | 828 | 779 |
Prepaid expenses and o... | https://www.sec.gov/Archives/edgar/data/0000318833/000031883323000018/tisi-20230331.htm | 74 | true | 10-Q|table_context|41+ | [
{
"fact_id": "a047f54206c375a9d476c65a0af937de582b582dfc8f55297db8ea0fabfbf9fa",
"concept": "us-gaap#CashAndCashEquivalentsAtCarryingValue",
"unit": "monetary:USD",
"period": "instant:2023-03-31",
"value": "31869000",
"displayed_text": "31,869",
"text_start": 114,
"text_end": 120,
... | [
{
"span_text": "31,",
"start": 10,
"end": 13,
"class": "date"
},
{
"span_text": "2023",
"start": 14,
"end": 18,
"class": "year"
},
{
"span_text": "31,",
"start": 30,
"end": 33,
"class": "date"
},
{
"span_text": "2022",
"start": 34,
"end": 38,
... |
0006f990a30c707617596836a4cde3f05c235bd062e31a37d4b47f07fce2161a | 0000894627 | EGY | VAALCO Energy, Inc. | 1311 | 000143774923030706 | 10-Q | 2023-11-08 | 2,023 | Q3 | table_context | null | $ 120 $ 121,612 11 Table of Contents | (in thousands)
| | Gabon
| | | Egypt
| | | Canada
| | | Equatorial Guinea
| | | Corporate and Other
| | | Total
| |
Long-lived assets from continuing operations:
| | | | | | | | | | | | | | | | | | | | | | | | |
As of September 30, 2023
| | $ | 1... | https://www.sec.gov/Archives/edgar/data/894627/000143774923030706/0001437749-23-030706-index.htm | 12 | true | 10-Q|table_context|6-15 | [
{
"fact_id": "9e3bd0fcf030c8248de40787d68715483bc333ef5ddf9ca7aaefbf92752266e5",
"concept": "us-gaap#NoncurrentAssets",
"unit": "monetary:USD",
"period": "instant:2023-09-30",
"value": "186966000",
"displayed_text": "186,966",
"text_start": 319,
"text_end": 326,
"dimensions": [
... | [
{
"span_text": "30,",
"start": 300,
"end": 303,
"class": "date"
},
{
"span_text": "2023",
"start": 304,
"end": 308,
"class": "year"
},
{
"span_text": "31,",
"start": 453,
"end": 456,
"class": "date"
},
{
"span_text": "2022",
"start": 457,
"end"... |
03be970c222e5c60e03ed31020983ebdc0bb95aaa9740733b1e27152dd725903 | 0001037540 | BXP | BOSTON PROPERTIES, INC. | 6798 | 000165642320000007 | 10-K | 2020-03-02 | 2,019 | FY | notes | 16. Stock Option and Incentive Plan | 2.68 % , 2.63 % and 2.14 % and an expected price volatility of 27.0 % , 27.0 % and 28.0 % , respectively. | There were no non-qualified stock options granted during the years ended December 31, 2019 , 2018 and 2017 .
A summary of the status of Boston Properties, Inc.’s stock options as of December 31, 2019 , 2018 and 2017 and changes during the years then ended are presented below:
| Shares
| Weighted-Average
Exercise Price
... | https://www.sec.gov/Archives/edgar/data/1037540/000165642320000007/bxpandbplp201910-k.htm | 15 | false | 10-K|notes|6-15 | [
{
"fact_id": "631bdb359ae290e18c4c7faf86e59937e4d4cb73a47938f2564a48281ce3386d",
"concept": "ext-0001037540#NonQualifiedStockOptionsIssued",
"unit": "shares",
"period": "instant:2019-12-31",
"value": "0",
"displayed_text": "no",
"text_start": 11,
"text_end": 13,
"dimensions": [],... | [
{
"span_text": "31,",
"start": 82,
"end": 85,
"class": "date"
},
{
"span_text": "2019",
"start": 86,
"end": 90,
"class": "year"
},
{
"span_text": "2018",
"start": 93,
"end": 97,
"class": "year"
},
{
"span_text": "2017",
"start": 102,
"end": 106... |
000a334a4124ccdc983d3a3b71f9c32d69b6bf516742e2582f164fa567d9d3f5 | 0000912593 | SUI | SUN COMMUNITIES, INC | 6798 | 000091259321000185 | 10-Q | 2021-07-27 | 2,021 | Q2 | table_context | (Unaudited) | three reportable segments are: (i) Manufactured home ("MH") communities, (ii) Recreational vehicle ("RV") resorts and (iii) Marinas. 7 SUN COMMUNITIES, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued) (Unaudited) 2. Revenue The following tables detail our revenue by major source (in thousands): | |
| Three Months Ended |
| June 30, 2021 | June 30, 2020 (1)
| MH | RV | Marina | Consolidated | MH | RV | Marina | Consolidated |
Revenues |
Real property | $ | 199,948 | $ | 132,463 | $ | 73,494 | $ | 405,905 | $ | 181,713 | $ | 69,414 | N/A | $ | 251,127 |
Home sales | 69,922 | 11,926 | — | 81,848 | 35,074 | 3,456 |... | https://www.sec.gov/Archives/edgar/data/912593/000091259321000185/sui-20210630.htm | 42 | true | 10-Q|table_context|41+ | [
{
"fact_id": "fa6e924b9fa6ead4393985ee1a3b48f4c75aa78604df41b712fafe0d8be4c01b",
"concept": "us-gaap#RevenueFromContractWithCustomerIncludingAssessedTax",
"unit": "monetary:USD",
"period": "duration:2021-04-01..2021-06-30",
"value": "199948000",
"displayed_text": "199,948",
"text_start":... | [
{
"span_text": "30,",
"start": 32,
"end": 35,
"class": "date"
},
{
"span_text": "2021",
"start": 36,
"end": 40,
"class": "year"
},
{
"span_text": "30,",
"start": 48,
"end": 51,
"class": "date"
},
{
"span_text": "2020",
"start": 52,
"end": 56,
... |
01c3b32aae1572a6376c0efb52643a5b1e6f7787bb485dbb16bee1edea25ac94 | 0001646972 | ACI | Albertsons Companies, Inc. | 5411 | 000164697219000054 | 10-Q | 2019-07-24 | 2,019 | Q1 | notes | Significant Accounting Policies | or omitted for the interim periods presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In the opinion of management, the interim data includes all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the results for the i... | Restricted cash: Restricted cash is included in Other current assets or Other assets depending on the remaining term of the restriction and primarily relates to funds held in escrow. The Company had $ 51.6 million and $ 41.6 million of restricted cash as of June 15, 2019 and February 23, 2019 , respectively.
Inventorie... | https://www.sec.gov/Archives/edgar/data/1646972/000164697219000054/aciq1-1910xq.htm | 5 | false | 10-Q|notes|2-5 | [
{
"fact_id": "aca671ed3283e29ffcb40b76f8cfe8f41babf9bd91e852706e2d1824a48eb893",
"concept": "us-gaap#RestrictedCash",
"unit": "monetary:USD",
"period": "instant:2019-06-15",
"value": "51600000",
"displayed_text": "51.6",
"text_start": 201,
"text_end": 205,
"dimensions": [],
"... | [
{
"span_text": "15,",
"start": 263,
"end": 266,
"class": "date"
},
{
"span_text": "2019",
"start": 267,
"end": 271,
"class": "year"
},
{
"span_text": "23,",
"start": 285,
"end": 288,
"class": "date"
},
{
"span_text": "2019",
"start": 289,
"end"... |
001ac321bf1bd1277c042710397044521f0653f5ba6e5e308165678257e54844 | 0001295810 | SHO | Sunstone Hotel Investors, Inc. | 7011 | 000110465926055508 | 10-Q | 2026-05-05 | 2,026 | Q1 | table_context | null | Table of Contents SUNSTONE HOTEL INVESTORS, INC. UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) Supplemental Disclosure of Cash Flow Information March 31, 2026 2025 Cash and cash equivalents $ 91,134 $ 72,334 Restricted cash 75,549 76,460 Total cash and cash equivalents and restricted cash shown on the ... | | Three Months Ended March 31,
| 2026
| 2025
Cash paid for interest, net of capitalized interest
| $
| 15,150
| $
| 13,004
Cash paid (refunded) for income taxes, net
| $
| 70
| $
| ( 145 )
Changes in operating lease right-of-use assets
| $
| 320
| $
| 1,203
Changes in operating lease obligations
| ( 537 )
| ( 1,344 )
C... | https://www.sec.gov/Archives/edgar/data/0001295810/000110465926055508/sho-20260331x10q.htm | 10 | true | 10-Q|table_context|6-15 | [
{
"fact_id": "a7abf848f167695698f307823ed1f741be89018ad06eda173222d1c1a577bbcd",
"concept": "us-gaap#InterestPaidNet",
"unit": "monetary:USD",
"period": "duration:2026-01-01..2026-03-31",
"value": "15150000",
"displayed_text": "15,150",
"text_start": 103,
"text_end": 109,
"dimens... | [
{
"span_text": "31,",
"start": 27,
"end": 30,
"class": "date"
},
{
"span_text": "2026",
"start": 33,
"end": 37,
"class": "year"
},
{
"span_text": "2025",
"start": 40,
"end": 44,
"class": "year"
}
] |
000b05069e23cf0959ece65864c5d3f954e763fe7c5fddc008b1258044689723 | 0001032208 | SRE | SEMPRA ENERGY | 4932 | 000008652118000091 | 10-Q | 2018-11-07 | 2,018 | Q3 | table_context | Sempra Energy | 74 LONG-TERM DEBT Sempra Energy On January 12, 2018, we issued the following debt securities and received net proceeds of $ 4.9 billion (after deducting discounts and debt issuance costs of $ 68 million ): | |
NOTES ISSUED IN LONG-TERM DEBT OFFERING
(Dollars in millions)
Title of each class of securities
| Aggregate principal amount
| Maturity
| Interest payments
Floating Rate (1) Notes due 2019
| $
| 500
| July 15, 2019
| Quarterly
Floating Rate (2) Notes due 2021
| 700
| January 15, 2021
| Quarterly
2.400% Senior Notes d... | https://www.sec.gov/Archives/edgar/data/1032208/000008652118000091/0000086521-18-000091-index.htm | 7 | true | 10-Q|table_context|6-15 | [
{
"fact_id": "8b9213ab3602439655a56195021f31c87fcc9e7d5a8a36ddf766a4e130a501f6",
"concept": "us-gaap#DebtInstrumentFaceAmount",
"unit": "monetary:USD",
"period": "instant:2018-01-12",
"value": "500000000",
"displayed_text": "500",
"text_start": 197,
"text_end": 200,
"dimensions":... | [
{
"span_text": "(1)",
"start": 172,
"end": 175,
"class": "other"
},
{
"span_text": "2019",
"start": 186,
"end": 190,
"class": "year"
},
{
"span_text": "15,",
"start": 208,
"end": 211,
"class": "date"
},
{
"span_text": "2019",
"start": 212,
"end... |
090432c6604a8e91712f65765aa2da08d499edd418b14821c09f1592a508375a | 0001596812 | ENLV | Enlivex Therapeutics Ltd. | 2834 | 000121390023028398 | 20-F | 2023-04-10 | 2,022 | FY | table_context | Research and development expenses – net | NOTE 16 – SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION a. Research and development expenses – net | Year
ended December 31, |
(in thousands ) |
2022 |
2021 |
2020 |
Payroll and related expenses |
$ | 6,371 |
$ | 5,054 |
$ | 3,183 |
Research and development services |
| 8,264 |
| 4,557 |
| 2,438 |
Materials |
| 2,044 |
| 1,505 |
| 612 |
Share Based Compensation |
| 876 |
| 1,210 |
| 401 |
Depreciation |
| 740 |
| 546 ... | https://www.sec.gov/Archives/edgar/data/1596812/000121390023028398/0001213900-23-028398-index.htm | 27 | true | 20-F|table_context|16-40 | [
{
"fact_id": "13fb38cc775ab5160100e7233188ec635e746412d33922385cb825faefeb9272",
"concept": "us-gaap#AccruedPayrollTaxesCurrent",
"unit": "monetary:USD",
"period": "instant:2022-12-31",
"value": "6371000",
"displayed_text": "6,371",
"text_start": 100,
"text_end": 105,
"dimensions... | [
{
"span_text": "31,",
"start": 20,
"end": 23,
"class": "date"
},
{
"span_text": "2022",
"start": 44,
"end": 48,
"class": "year"
},
{
"span_text": "2021",
"start": 51,
"end": 55,
"class": "year"
},
{
"span_text": "2020",
"start": 58,
"end": 62,
... |
43c3b0b24c2c1abfc7381d3eea374e8505e7d04661ce3174505ea08dff0b46f6 | 0001302215 | HLI | Houlihan Lokey, Inc. | 6282 | 000130221520000074 | 10-K | 2020-05-15 | 2,020 | FY | table_context | null | er the 2016 Incentive Plan by approximately 12.2 million shares. Under the Amendment, the aggregate number of shares of common stock that are available for issuance under awards granted pursuant to the 2016 Incentive Plan is equal to the sum of (i) 8.0 million and (ii) any shares of our Class B common stock that are su... | |
•
| 6,540,659 shares of our Class A common stock and Class B common stock; | https://www.sec.gov/Archives/edgar/data/1302215/000130221520000074/0001302215-20-000074-index.htm | 1 | false | 10-K|table_context|1 | [
{
"fact_id": "a47bb0c79b79e06f24cad98a6afaf2b94021075ea987daf432355795abbf81a7",
"concept": "ext-0001302215#ShareBasedCompensationArrangementBySharebasedPaymentAwardIncreaseDecreaseToNumberofSharesAuthorized",
"unit": "shares",
"period": "instant:2017-10-19",
"value": "6540659",
"displayed_t... | [] |
00186790c8733c2217e890362bb3122b5396dae770c419e1f7f3d670cecd91f1 | 0001464865 | ASII | Accredited Solutions, Inc. | 2080 | 000147793222002592 | 10-K | 2022-04-25 | 2,021 | FY | notes | NOTE 10 – JOINT VENTURE | in convertible debt. See Note 5. On November 17, 2021, the Company issued 83,043 shares of common stock to GS Capital, LLC for a conversion of $ 8,745 in convertible debt. See Note 5. On December 13, 2021, the Company issued 224,964 shares of common stock to GS Capital, LLC for a conversion of $ 8,774 in convertible de... | On August 24, 2020, with an effective date of July 1, 2020, the Company entered into a joint venture agreement with Paul Hervey (“Hervey”) for the purpose of cultivating hemp. Hervey is a licensed hemp cultivator in good standing under the laws of North Carolina with approximately 3,700 square feet of greenhouse cultiv... | https://www.sec.gov/Archives/edgar/data/0001464865/000147793222002592/ghmp_10k.htm | 8 | false | 10-K|notes|6-15 | [
{
"fact_id": "e5b0364f63359a1dc6aee3a839da22648e1e94b42ffea2dc120ba3cd551cec9a",
"concept": "us-gaap#ContributionOfProperty",
"unit": "monetary:USD",
"period": "duration:2020-08-02..2020-08-24",
"value": "160000",
"displayed_text": "160,000",
"text_start": 462,
"text_end": 469,
"... | [
{
"span_text": "24,",
"start": 10,
"end": 13,
"class": "date"
},
{
"span_text": "2020,",
"start": 14,
"end": 19,
"class": "year"
},
{
"span_text": "1,",
"start": 51,
"end": 53,
"class": "date"
},
{
"span_text": "2020,",
"start": 54,
"end": 59,
... |
000a9f175c8bfa927f1ad90f747075b3e3a9808a7565bf96cf9b84b5c318a373 | 0001522727 | USAC | USA Compression Partners, LP | 4922 | 000152272721000029 | 10-Q | 2021-08-03 | 2,021 | Q2 | notes | (11) Revenue Recognition | no t included in the computation as they are not considered “in the money” for either period. 14 Table of Contents (11) Revenue Recognition Disaggregation of Revenue | The following table disaggregates our revenue by type of service (in thousands):
| Three Months Ended June 30, | Six Months Ended June 30, |
| 2021 | 2020 | 2021 | 2020 |
Contract operations revenue | $ | 154,733 | $ | 166,101 | $ | 310,202 | $ | 342,003 |
Retail parts and services revenue | 1,829 | 2,550 | 3,873 | 5,6... | https://www.sec.gov/Archives/edgar/data/1522727/000152272721000029/0001522727-21-000029-index.htm | 42 | true | 10-Q|notes|16-40 | [
{
"fact_id": "5cf74b367bcb603c7c41ed4fc04c419243011f53e1abbb505c61b3a2c2002e80",
"concept": "us-gaap#RevenueFromContractWithCustomerExcludingAssessedTax",
"unit": "monetary:USD",
"period": "duration:2021-04-01..2021-06-30",
"value": "154733000",
"displayed_text": "154,733",
"text_start":... | [
{
"span_text": "30,",
"start": 107,
"end": 110,
"class": "date"
},
{
"span_text": "30,",
"start": 135,
"end": 138,
"class": "date"
},
{
"span_text": "2021",
"start": 143,
"end": 147,
"class": "year"
},
{
"span_text": "2020",
"start": 150,
"end"... |
00280cd869dd8c0020013805a736ac15244549f7ed360cd387ec475524ed772c | 0000894556 | CITR | General Enterprise Ventures, Inc. | 2800 | 000164033424001748 | 10-Q | 2024-11-18 | 2,024 | Q3 | table_context | Revenue and accounts receivable | Remaining Shares Exercise Price Contractual life (in years) Outstanding, December 31, 2023 - $ - - Granted 1,401,250 0.50 5 .00 Exercised - - - Forfeited/canceled - - - Outstanding, September 30, 2024 1,401,250 $ 0.50 4.82 The intrinsic value of the warrants as of September 30, 2024 is $262,734. Note 10– Commitments an... | | Percentage of Revenue
| Percentage of
| For Nine Months Ended
| Accounts Receivable
| September 30,
| September 30
| December 31
| 2024
| 2023
| 2024
| 2023
Customer A
| 28.16 | % |
| - |
| - |
| - |
Customer B
| 14.97 | % |
| - |
| 15.56 | % |
| - |
Customer C
| 11.91 | % |
| - |
| - |
| - |
Customer D
| 21.39 | % |... | https://www.sec.gov/Archives/edgar/data/0000894556/000164033424001748/gevi_10q.htm | 15 | false | 10-Q|table_context|6-15 | [
{
"fact_id": "dfa208bfea1f79944bfb5e253d34f946afb045e4156ab63e633c120d57225b5a",
"concept": "ext-0000894556#ConcentrationRiskPercentage",
"unit": "pure",
"period": "duration:2024-01-01..2024-09-30",
"value": "0.2816",
"displayed_text": "28.16",
"text_start": 172,
"text_end": 177,
... | [
{
"span_text": "30,",
"start": 98,
"end": 101,
"class": "date"
},
{
"span_text": "30",
"start": 114,
"end": 116,
"class": "date"
},
{
"span_text": "31",
"start": 128,
"end": 130,
"class": "date"
},
{
"span_text": "2024",
"start": 133,
"end": 13... |
002a8db42e119e8c76a8b24250a56a6166320807a1a34ab9cef11dfb1893bbdf | 0000831641 | TTEK | TETRA TECH, INC. | 8711 | 000083164126000011 | 10-Q | 2026-05-01 | 2,026 | Q2 | table_context | (unaudited – in thousands) (part 1) | $ 199,744 $ ( 68,170 ) See Notes to Consolidated Financial Statements. 5 Tetra Tech, Inc. Consolidated Statements of Cash Flows (unaudited – in thousands) | | Six Months Ended |
| March 29, 2026 | March 30, 2025 |
Cash flows from operating activities: |
Net income | $ | 199,020 | $ | 6,190 |
Adjustments to reconcile net income to net cash provided by operating activities: |
Depreciation and amortization | 28,337 | 29,939 |
Amortization of stock-based awards | 17,670 | 17,0... | https://www.sec.gov/Archives/edgar/data/0000831641/000083164126000011/ttek-20260329.htm | 88 | true | 10-Q|table_context|41+ | [
{
"fact_id": "754545e53a376e01b2e0ce527bef21a076e5f783172a73720c4d47cd152289e2",
"concept": "us-gaap#ProfitLoss",
"unit": "monetary:USD",
"period": "duration:2025-09-29..2026-03-29",
"value": "199020000",
"displayed_text": "199,020",
"text_start": 114,
"text_end": 121,
"dimension... | [
{
"span_text": "29,",
"start": 29,
"end": 32,
"class": "date"
},
{
"span_text": "2026",
"start": 33,
"end": 37,
"class": "year"
},
{
"span_text": "30,",
"start": 46,
"end": 49,
"class": "date"
},
{
"span_text": "2025",
"start": 50,
"end": 54,
... |
01add27ecc1e1b400d377f77e6dcc3e13d44a95786c455fe85945583c17a58c1 | 0000879635 | MPB | MID PENN BANCORP, INC. | 6022 | 000087963522000010 | 10-Q | 2022-11-04 | 2,022 | Q3 | table_context | null | s (losses) on defined benefit plans during the period. (3) The reclassification adjustment for benefit plans includes settlement gains, amortization of prior service costs, and amortization of net gain or loss. Amounts are included in other income on the consolidated statements of income within total noninterest income... | |
(Dollars in thousands) |
| Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Treasury Stock | Total Shareholders' Equity |
Balance, January 1, 2022 | $ | 16,056 | $ | 384,742 | $ | 91,043 | $ | 158 | $ | ( 1,923 ) | $ | 490,076 |
Net income | — | — | 11,35... | https://www.sec.gov/Archives/edgar/data/879635/000087963522000010/0000879635-22-000010-index.htm | 84 | true | 10-Q|table_context|41+ | [
{
"fact_id": "b12d58c2bbfbbcb922ed068b04795108ea7d63430963cd0711853b39cc154c6a",
"concept": "us-gaap#StockholdersEquity",
"unit": "monetary:USD",
"period": "instant:2021-12-31",
"value": "16056000",
"displayed_text": "16,056",
"text_start": 218,
"text_end": 224,
"dimensions": [
... | [
{
"span_text": "1,",
"start": 204,
"end": 206,
"class": "date"
},
{
"span_text": "2022",
"start": 207,
"end": 211,
"class": "year"
},
{
"span_text": "31,",
"start": 810,
"end": 813,
"class": "date"
},
{
"span_text": "2022",
"start": 814,
"end":... |
0011ed5f9a81d03c20a1fb89517f9543ec341d49061ce44454528664a8fbc51f | 0000908937 | SIRI | SIRIUS XM HOLDINGS INC. | 4832 | 000090893723000006 | 10-K | 2023-02-02 | 2,022 | FY | notes | (16) Commitments and Contingencies | o agreements with third parties to operate and maintain satellite telemetry, tracking and control facilities and certain components of our terrestrial repeater networks. Programming and content. We have entered into various programming and content agreements. Under the terms of these agreements, our obligations include... | Sales and marketing. We have entered into various marketing, sponsorship and distribution agreements to promote our brands and are obligated to make payments to sponsors, retailers, automakers, radio manufacturers and other third parties under these agreements. Certain programming and content agreements also require us... | https://www.sec.gov/Archives/edgar/data/908937/000090893723000006/siri-20221231.htm | 3 | true | 10-K|notes|2-5 | [
{
"fact_id": "91d4914294c188f951240b4d814065ebcf989780924c97d6b808fa527a8f2509",
"concept": "us-gaap#OperatingLeaseExpense",
"unit": "monetary:USD",
"period": "duration:2022-01-01..2022-12-31",
"value": "68000000",
"displayed_text": "68",
"text_start": 1392,
"text_end": 1394,
"di... | [
{
"span_text": "33",
"start": 399,
"end": 401,
"class": "untagged_amount"
},
{
"span_text": "5,",
"start": 776,
"end": 778,
"class": "other"
},
{
"span_text": "5,",
"start": 789,
"end": 791,
"class": "other"
},
{
"span_text": "6,",
"start": 802,
... |
001ce58c0509a274964cb42072d04bdb656f27852d42e878097ff68f2703d743 | 0001002047 | NTAP | NetApp, Inc. | 3572 | 000156459020005025 | 10-Q | 2020-02-18 | 2,020 | Q3 | table_context | Product warranty liabilities: | $ 851 Product warranty liabilities: Equipment and software systems sales include a standard product warranty. The following tables summarize the activity related to product warranty liabilities and their balances as reported in our condensed consolidated balance sheets (in millions): | Three Months Ended
Nine Months Ended
January 24,
2020
January 25,
2019
January 24,
2020
January 25,
2019
Balance at beginning of period
$
40
$
39
$
40
$
40
Expense accrued during the period
7
6
19
16
Warranty costs incurred
( 6
)
( 6
)
( 18
)
( 17
)
Balance at end of period
$
41
$
39
$
41
$
39 | https://www.sec.gov/Archives/edgar/data/1002047/000156459020005025/ntap-10q_20200124.htm | 16 | true | 10-Q|table_context|6-15 | [
{
"fact_id": "9aaacaf2fd0995bf718600f67aee014344ae6794b0bd75ac2b23b51f4285625c",
"concept": "us-gaap#StandardProductWarrantyAccrual",
"unit": "monetary:USD",
"period": "instant:2019-10-25",
"value": "40000000",
"displayed_text": "40",
"text_start": 138,
"text_end": 140,
"dimensio... | [
{
"span_text": "24,",
"start": 45,
"end": 48,
"class": "date"
},
{
"span_text": "2020",
"start": 49,
"end": 53,
"class": "year"
},
{
"span_text": "25,",
"start": 62,
"end": 65,
"class": "date"
},
{
"span_text": "2019",
"start": 66,
"end": 70,
... |
00313f1f222f141f8add725ca998be99f667debaf403d66fc7ba47f27188c7d2 | 0001419536 | CBNK | CAPITAL BANCORP INC | 6021 | 000162828024011467 | 10-K | 2024-03-15 | 2,023 | FY | table_context | Capital Bancorp, Inc. and Subsidiaries | 41,804 114 Capital Bancorp, Inc. and Subsidiaries Notes to Consolidated Financial Statements December 31, 2023 and 2022 Note 16 - Parent Company Financial Information (continued) | Parent Company Only Statements of Cash Flows |
(in thousands) | 2023 | 2022 |
Cash flows from operating activities |
Net Income
| $ | 35,871 | $ | 41,804 |
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses | 88 | — |
Undistributed net income of subsidiaries | ... | https://www.sec.gov/Archives/edgar/data/1419536/000162828024011467/0001628280-24-011467-index.htm | 42 | true | 10-K|table_context|41+ | [
{
"fact_id": "ee2716389963cdb177f669787c926313d921d5a766defc3d552b9de96304e1f8",
"concept": "us-gaap#NetIncomeLoss",
"unit": "monetary:USD",
"period": "duration:2023-01-01..2023-12-31",
"value": "35871000",
"displayed_text": "35,871",
"text_start": 134,
"text_end": 140,
"dimensio... | [
{
"span_text": "2023",
"start": 64,
"end": 68,
"class": "year"
},
{
"span_text": "2022",
"start": 71,
"end": 75,
"class": "year"
}
] |
050b7e590145bf05a048ab315e632e64ec65258853f5151b464a4057237c6a05 | 0000866439 | DPLS | DarkPulse, Inc. | 7372 | 000168316823004978 | 10-Q | 2023-07-18 | 2,023 | Q1 | table_context | Balance at March 31, 2023 (unaudited) | $ 1 88,235 $ 883 7,256,066,860 $ 725,608 | Treasury stock |
Additional paid-in |
Non- controlling |
Accumulated other com- prehensive |
Accumulated |
Total
stockholders’
deficit
Shares |
Amount |
capital |
interests |
loss |
deficit |
(equity) |
Balance at December 31, 2021 |
| 100,000 |
$ | ( 1,000 | ) |
$ | 20,248,703 |
$ | 2,358,227 |
$ | ( 284,463 | ) |
$ |... | https://www.sec.gov/Archives/edgar/data/0000866439/000168316823004978/darkpulse_i10q-033123.htm | 43 | false | 10-Q|table_context|41+ | [
{
"fact_id": "53f952b14c01e95bd0c0e39fd26979b7b7d609725c1a4a72269b53a2dc203996",
"concept": "us-gaap#SharesOutstanding",
"unit": "shares",
"period": "instant:2021-12-31",
"value": "100000",
"displayed_text": "100,000",
"text_start": 236,
"text_end": 243,
"dimensions": [
{
... | [
{
"span_text": "31,",
"start": 223,
"end": 226,
"class": "date"
},
{
"span_text": "2021",
"start": 227,
"end": 231,
"class": "year"
},
{
"span_text": "31,",
"start": 716,
"end": 719,
"class": "date"
},
{
"span_text": "2022",
"start": 720,
"end"... |
0b52f02ba337df49516fffe8ce21466b6af82be87acf98096110cb3abae05b03 | 0001818382 | HUMA | Humacyte, Inc. | 2836 | 000181838224000056 | 10-Q | 2024-05-13 | 2,024 | Q1 | table_context | (unaudited) | luates assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level at which to classify them for each reporting period, utilizing valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The ... | ($ in thousands) | Fair Value Measured as of March 31, 2024
Level 1 | Level 2 | Level 3 | Total |
Assets: |
Cash equivalents (money market funds) | $ | 113,714 | $ | — | $ | — | $ | 113,714 |
Total financial assets | $ | 113,714 | $ | — | $ | — | $ | 113,714 |
Liabilities: |
Contingent Earnout Liability | $ | — | $ | —... | https://www.sec.gov/Archives/edgar/data/1818382/000181838224000056/huma-20240331.htm | 32 | true | 10-Q|table_context|16-40 | [
{
"fact_id": "4c0e9522e79cfb80e8b63deb892415292d66f828e2bf13f3313dafa7be056b11",
"concept": "us-gaap#CashAndCashEquivalentsFairValueDisclosure",
"unit": "monetary:USD",
"period": "instant:2024-03-31",
"value": "113714000",
"displayed_text": "113,714",
"text_start": 152,
"text_end": 1... | [
{
"span_text": "31,",
"start": 51,
"end": 54,
"class": "date"
},
{
"span_text": "2024",
"start": 55,
"end": 59,
"class": "year"
},
{
"span_text": "1",
"start": 66,
"end": 67,
"class": "date"
},
{
"span_text": "2",
"start": 76,
"end": 77,
"c... |
00bba2d783ef582c242447757389cec4e19ded99559e16c62385dbe8bba23414 | 0001761612 | BCYC | BICYCLE THERAPEUTICS PLC | 2834 | 000155837023017317 | 10-Q | 2023-11-02 | 2,023 | Q3 | notes | Bayer Collaboration Agreement | cludes research and development services during the research term associated with radiopharmaceutical compounds directed to the third target, as well as underlying options for: certain limited substitution rights; an option to progress a radiopharmaceutical candidate directed to the third target into further developmen... | The Company’s participation in the joint research committee was assessed as immaterial in the context of the contract.
The Company concluded that the license granted at contract inception is not distinct from the research and development services as Bayer cannot obtain the benefit of the license without the Company per... | https://www.sec.gov/Archives/edgar/data/1761612/000155837023017317/0001558370-23-017317-index.htm | 17 | true | 10-Q|notes|6-15 | [
{
"fact_id": "4038917af6d308574e624327c280d8b0a74515afdcbb21d94648cc87f460c777",
"concept": "ext-0001761612#RevenueRecognitionAllocatedDeterminedTransactionPrice",
"unit": "monetary:USD",
"period": "instant:2023-05-04",
"value": "47500000",
"displayed_text": "47.5",
"text_start": 1345,
... | [
{
"span_text": "17",
"start": 1269,
"end": 1271,
"class": "untagged_amount"
},
{
"span_text": "606,",
"start": 2277,
"end": 2281,
"class": "note_ref"
},
{
"span_text": "606",
"start": 2328,
"end": 2331,
"class": "note_ref"
},
{
"span_text": "30,",
... |
00414f677429cb8439f3b816c9d2494c8e251c369b8c46aa3ebfa246afc7e160 | 0000855683 | MLSS | MILESTONE SCIENTIFIC INC. | 3842 | 000143774922020528 | 10-Q | 2022-08-15 | 2,022 | Q2 | table_context | Warrants | 23,000 for the three and six months ended June 30, 2021, respectively The annual amortization expense expected to be recorded for existing intangibles assets for the years 2022 through 2026 and thereafter, is approximately $ 27,000 , $ 52,000 , $ 34,000 , $ 28,000 and $ 110,000 . NOTE 8 — STOCKHOLDERS ’ EQUITY Warrants... | | | Warrant shares outstanding
| | | Weighted Average exercise price
| | | Weighted Average remaining life
| | | Intrinsic value
| |
| | | | | | | | | | | | | | | | |
Outstanding at January 1, 2022
| | | 4,268,221 | | | | 2.18 | | | | 1.50 | | | | ... | https://www.sec.gov/Archives/edgar/data/855683/000143774922020528/0001437749-22-020528-index.htm | 10 | false | 10-Q|table_context|6-15 | [
{
"fact_id": "68d29d74fcb30b35753a35917d93168c925f98769ae17fbf8716a2d42b690b1d",
"concept": "us-gaap#ClassOfWarrantOrRightOutstanding",
"unit": "shares",
"period": "instant:2021-12-31",
"value": "4268221",
"displayed_text": "4,268,221",
"text_start": 258,
"text_end": 267,
"dimens... | [
{
"span_text": "1,",
"start": 240,
"end": 242,
"class": "date"
},
{
"span_text": "2022",
"start": 243,
"end": 247,
"class": "year"
},
{
"span_text": "1.50",
"start": 301,
"end": 305,
"class": "untagged_amount"
},
{
"span_text": "30,",
"start": 521,... |
002d1b70cbfee0ebb22d06afb5ace2e4abdd82c6d78f29f9fa2b34e896e49b1d | 0002020455 | ETH | Grayscale Ethereum Staking Mini ETF | 6221 | 000095017025062747 | 10-Q | 2025-05-02 | 2,025 | Q1 | notes | PART I – FINANCIAL INFORMATION: Item 1. Financial Statements (Unaudited) GRAYSCALE ETHEREUM MINI TRUST ETF STATEMENTS OF ASSETS AND LIABILITIES (UNAUDITED) (Amounts in thousands, except Share and per | (1) No comparative financial statements have been provided as the Trust’s operations commenced on July 23, 2024. Prior to the commencement of operations on July 23, 2024, the Sponsor redeemed the initial seed capital of 10,000 shares for $ 100,000 . | See accompanying notes to the unaudited financial statements.
7
GRAYSCALE ETHEREUM MINI TRUST ETF
STATEMENT OF CASH FLOWS (UNAUDITED)
(Amounts in thousands)
Three Months Ended March 31, 2025 (1)
Cash provided by operating activities
Net decrease in net assets resulting from operations
$
( 717,285
)
Adjustments to recon... | https://www.sec.gov/Archives/edgar/data/2020455/000095017025062747/0000950170-25-062747-index.htm | 17 | true | 10-Q|notes|16-40 | [
{
"fact_id": "287066e0fcb5d33b7f35d9d32b9a823aa961bd12a892893be80b80c9ac67b81d",
"concept": "us-gaap#NetIncomeLoss",
"unit": "monetary:USD",
"period": "duration:2025-01-01..2025-03-31",
"value": "-717285000",
"displayed_text": "717,285",
"text_start": 290,
"text_end": 297,
"dimen... | [
{
"span_text": "7",
"start": 62,
"end": 63,
"class": "other"
},
{
"span_text": "31,",
"start": 182,
"end": 185,
"class": "date"
},
{
"span_text": "2025",
"start": 186,
"end": 190,
"class": "year"
},
{
"span_text": "(1)",
"start": 191,
"end": 19... |
0055897803ec2121cc3981324d1b48e769320b7cadc1d2208f31d5956ceab464 | 0001121795 | GHST | GHST World Inc | 7372 | 000155335023000446 | 10-K | 2023-10-13 | 2,023 | FY | table_context | null | 39,181 ( 39,181 ) — Total $ 154,181 $ ( 154,181 ) $ — | For The Year Ended June 30, 2022 |
As previously reported |
Restatement Adjustment |
As restated |
Consolidated Statement of Operations |
General and administrative expenses |
$ | 150,702 |
$ | 14,521 |
$ | 165,223 |
Impairment of long-lived assets |
| — |
$ | 154,181 |
$ | 154,181 |
Loss on debt conversion |
| — |
$ |... | https://www.sec.gov/Archives/edgar/data/1121795/000155335023000446/0001553350-23-000446-index.htm | 26 | false | 10-K|table_context|16-40 | [
{
"fact_id": "fa323b18c11fd351296b79614dfb8ac0dbdda185bc8c87a061c9c472e4f5cdf3",
"concept": "us-gaap#GeneralAndAdministrativeExpense",
"unit": "monetary:USD",
"period": "duration:2021-07-01..2022-06-30",
"value": "150702",
"displayed_text": "150,702",
"text_start": 180,
"text_end": 1... | [
{
"span_text": "30,",
"start": 24,
"end": 27,
"class": "date"
},
{
"span_text": "2022",
"start": 28,
"end": 32,
"class": "year"
}
] |
00255bdca77b6beed48f304c3d741776fd83deab1184282f30f39f1f8acfffe6 | 0001000209 | MFIN | MEDALLION FINANCIAL CORP | 6199 | 000095017023007273 | 10-K | 2023-03-10 | 2,022 | FY | legal | (D) OTHER LITIGATION AND REGULATORY MATTERS | vigorously and believe that the SEC will not prevail on its claims. Nevertheless, depending on the outcome of the litigation, the Company could incur a loss and other penalties that could be material to the Company, its results of operations and/or financial condition, as well as a bar against its President and Chief O... | The Company and its subsidiaries are subject to inquiries from certain regulators and are currently involved in various legal proceedings incident to the normal course of business, including collection matters with respect to certain loans. The Company intends to vigorously defend any outstanding claims and pursue its ... | https://www.sec.gov/Archives/edgar/data/0001000209/000095017023007273/mfin-20221231.htm | 9 | false | 10-K|narrative_other|6-15 | [
{
"fact_id": "3ab5c352e49d9670c32fb88dca9f768510be4aeb4453ed9705e077860f929cfa",
"concept": "us-gaap#SalariesWagesAndOfficersCompensation",
"unit": "monetary:USD",
"period": "duration:2022-01-01..2022-12-31",
"value": "239000000",
"displayed_text": "239,000",
"text_start": 1106,
"tex... | [
{
"span_text": "(11)",
"start": 691,
"end": 695,
"class": "other"
},
{
"span_text": "2022",
"start": 1142,
"end": 1146,
"class": "year"
},
{
"span_text": "2021,",
"start": 1151,
"end": 1156,
"class": "year"
},
{
"span_text": "1,",
"start": 1208,
... |
005b365e68fa8d62f897dce69efb8c8c6da94aaa7ef578842ddd649811ff5c9f | 0001598599 | IPHA | Innate Pharma SA | 2836 | 000159859925000042 | 20-F | 2025-04-30 | 2,024 | FY | table_context | null | € 14.61 € 10.55 € 5.83 € 10.30 € 90 | AGAP Management 2017 | AGA Bonus 2018 | AGA Perf Employees 2018 | AGA Perf Management 2018 | AGA New Members 2017-1 |
Date of grant (Board of Directors) | April 3, 2018 | July 3, 2018 | November 20, 2018 | November 20, 2018 | April 29, 2019 |
Vesting period (years) | 1 year | 1 year | 3 years | 3 years | 3 years |
Non ... | https://www.sec.gov/Archives/edgar/data/0001598599/000159859925000042/inpha-20241231.htm | 35 | false | 20-F|table_context|16-40 | [
{
"fact_id": "8bde6b987dfce78d78c0f764ae288a45d44759cfa41d51edf869d93a53dc3b13",
"concept": "ifrs#NumberOfInstrumentsOtherEquityInstrumentsGranted",
"unit": "shares",
"period": "duration:2018-04-03..2018-04-03",
"value": "2400",
"displayed_text": "2,400",
"text_start": 475,
"text_end... | [
{
"span_text": "2017",
"start": 16,
"end": 20,
"class": "year"
},
{
"span_text": "2018",
"start": 33,
"end": 37,
"class": "year"
},
{
"span_text": "2018",
"start": 59,
"end": 63,
"class": "year"
},
{
"span_text": "2018",
"start": 86,
"end": 90,... |
0026b09d784c297f99181281ec3d4171435a511bf2c9a3e22cb309e6237ddb1b | 0001372920 | EDU | NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. | 8200 | 000119312521282201 | 20-F | 2021-09-24 | 2,021 | FY | notes | US$ | no impairment loss was recorded from this investment. (f) The Group holds several insignificant investments in third-party private companies and has no ability to exercise significant influence over the investees. Those investments were accounted using the measurement alternative when there is no readily determinable f... | (g) |
In July 2018, Education Industry Fund was established with the total committed capital of US$ 224,000 . There are two general partners in the fund, which include an entity invested by Mr. Yu and an unrelated third party. The Group participates in the Education Industry Fund as a limited partner and invested
US$ 8... | https://www.sec.gov/Archives/edgar/data/0001372920/000119312521282201/d159008d20f.htm | 12 | false | 20-F|notes|6-15 | [
{
"fact_id": "a544b84962092e9dafb9322c91baf2b5358e30ea2cbf97adcb9e66cf33e0d56e",
"concept": "ext-0001372920#CommittedCapitalContribution",
"unit": "monetary:USD",
"period": "duration:2018-07-01..2018-07-31",
"value": "224000000",
"displayed_text": "224,000",
"text_start": 100,
"text_... | [
{
"span_text": "2018,",
"start": 14,
"end": 19,
"class": "year"
},
{
"span_text": "31,",
"start": 367,
"end": 370,
"class": "date"
},
{
"span_text": "2021",
"start": 371,
"end": 375,
"class": "year"
},
{
"span_text": "323,",
"start": 462,
"end"... |
0021330d56a3e6cb08a46bf8b9efc035edd61e8bd554adf1b0778f77e1dfe49a | 0001456772 | OPI | OFFICE PROPERTIES INCOME TRUST | 6500 | 000145677226000020 | 10-Q | 2026-05-22 | 2,025 | Q3 | notes | (dollars in thousands, except per share data)(unaudited) | s employees assigned to work exclusively or partly at our properties, our share of the wages, benefits and other related costs of RMR’s centralized accounting personnel, our share of RMR’s costs for providing our internal audit function and as otherwise agreed. Our property level operating expenses are generally incorp... | For the three and nine months ended September 30, 2025 and 2024, the business management fees, property management fees and construction supervision fees and expense reimbursements recognized in our condensed consolidated financial statements were as follows:
Financial Statement | Three Months Ended September 30, | Nin... | https://www.sec.gov/Archives/edgar/data/1456772/000145677226000020/0001456772-26-000020-index.htm | 39 | true | 10-Q|notes|16-40 | [
{
"fact_id": "313d4d30df45ae23d482a349b5d40f53cc61d17ee509d2a4235e0ed1a9ff862f",
"concept": "us-gaap#RelatedPartyTransactionAmountsOfTransaction",
"unit": "monetary:USD",
"period": "duration:2025-07-01..2025-09-30",
"value": "3063000",
"displayed_text": "3,063",
"text_start": 509,
"t... | [
{
"span_text": "30,",
"start": 46,
"end": 49,
"class": "date"
},
{
"span_text": "2025",
"start": 50,
"end": 54,
"class": "year"
},
{
"span_text": "2024,",
"start": 59,
"end": 64,
"class": "year"
},
{
"span_text": "30,",
"start": 311,
"end": 314... |
014f9344ece4734fa4c55c49f5773704f8476a62bb6e9f02da9159da2185305d | 0000825542 | SMG | Scotts Miracle-Gro Co | 2870 | 000154638024000007 | 10-Q | 2024-02-07 | 2,024 | Q1 | table_context | null | ( 72.2 ) $ ( 169.3 ) The sum of the components may not equal due to rounding. Share-Based Awards In January 2024, the shareholders of Scotts Miracle-Gro approved an amendment and restatement of The Scotts Miracle-Gro Company Long-Term Incentive Plan to increase the maximum number of Common Shares available for grant to... | Three Months Ended |
December 30, 2023 | December 31, 2022 |
Share-based compensation | $ | 16.0 | $ | 20.9 |
Related tax benefit recognized | 2.6 | 4.7 | | https://www.sec.gov/Archives/edgar/data/825542/000154638024000007/0001546380-24-000007-index.htm | 4 | false | 10-Q|table_context|2-5 | [
{
"fact_id": "2b8f459770fb2e5a7afaf0f8ed1c27898a4f1f2a4d043534bc4e01b11395ae83",
"concept": "us-gaap#ShareBasedCompensation",
"unit": "monetary:USD",
"period": "duration:2023-10-01..2023-12-30",
"value": "16000000",
"displayed_text": "16.0",
"text_start": 92,
"text_end": 96,
"dim... | [
{
"span_text": "30,",
"start": 30,
"end": 33,
"class": "date"
},
{
"span_text": "2023",
"start": 34,
"end": 38,
"class": "year"
},
{
"span_text": "31,",
"start": 50,
"end": 53,
"class": "date"
},
{
"span_text": "2022",
"start": 54,
"end": 58,
... |
00c634f162882d20574196d118725f8c01178807048eafd3cb3763b67c83c9f0 | 0001822479 | SHC | SOTERA HEALTH COMPANY | 8090 | 000182247923000051 | 10-Q | 2023-08-03 | 2,023 | Q2 | table_context | null | (e) 69,888 — 69,888 — | |
As of December 31, 2022 | Fair Value |
(thousands of U.S. dollars) | Carrying Amount | Level 1
| Level 2
| Level 3
Derivatives designated as hedging instruments (a)
Interest rate caps | $ | 34,764 | $ | — | $ | 34,764 | $ | — |
Derivatives not designated as hedging instruments (b)
Foreign currency forward contracts |... | https://www.sec.gov/Archives/edgar/data/1822479/000182247923000051/shc-20230630.htm | 32 | false | 10-Q|table_context|16-40 | [
{
"fact_id": "dafad65f94602420c8a5cd93442bfc6b574249e9654de1371be4a2ee6022981b",
"concept": "us-gaap#DerivativeFairValueOfDerivativeAsset",
"unit": "monetary:USD",
"period": "instant:2022-12-31",
"value": "34764000",
"displayed_text": "34,764",
"text_start": 192,
"text_end": 198,
... | [
{
"span_text": "31,",
"start": 17,
"end": 20,
"class": "date"
},
{
"span_text": "2022",
"start": 21,
"end": 25,
"class": "year"
},
{
"span_text": "1",
"start": 95,
"end": 96,
"class": "note_ref"
},
{
"span_text": "2",
"start": 105,
"end": 106,
... |
007735e396258163690cdb8a3bae6a7a989efed030664e88957211530c74e307 | 0001230058 | KANP | KAANAPALI LAND, LLC | 6552 | 000089262624000006 | 10-K | 2024-03-27 | 2,023 | FY | table_context | (Dollars in Thousands, except share data) | /s/ GRANT THORNTON LLP We have served as the Company’s auditor since 2015. Dallas, Texas March 27, 2024 31 Table of Contents Kaanapali Land, LLC Consolidated Balance Sheets December 31, 2023 and 2022 (Dollars in Thousands, except share data) | 2023 |
2022 |
Assets |
Cash and cash equivalents |
$ |
26,260 |
$ |
19,815 |
Property, net |
60,200 |
58,988 |
Investments |
-- |
19,115 |
Retirement plan investments |
5,067 |
-- |
Other assets |
1,492 |
596 |
Total assets |
$ |
93,019 |
$ |
98,514 |
Liabilities |
Accounts payable and accrued expenses |
$ |
346 |
$ |
... | https://www.sec.gov/Archives/edgar/data/0001230058/000089262624000006/kaana10k-2023.htm | 38 | true | 10-K|table_context|16-40 | [
{
"fact_id": "de854826bb5f4686c768a92c1c7608a5dfc0e1ac81ffad1a06c4a396f44cc4dd",
"concept": "us-gaap#CashAndCashEquivalentsAtCarryingValue",
"unit": "monetary:USD",
"period": "instant:2023-12-31",
"value": "26260000",
"displayed_text": "26,260",
"text_start": 55,
"text_end": 61,
... | [
{
"span_text": "2023",
"start": 0,
"end": 4,
"class": "year"
},
{
"span_text": "2022",
"start": 7,
"end": 11,
"class": "year"
},
{
"span_text": "7)",
"start": 521,
"end": 523,
"class": "note_ref"
},
{
"span_text": "12",
"start": 553,
"end": 555... |
00c897a8ea424225c57f17c76d36ba82ba29d482d87054684680a6b5405de435 | 0001341439 | ORCL | ORACLE CORP | 7372 | 000095017024075605 | 10-K | 2024-06-20 | 2,024 | FY | table_context | null | ir hardware products and can also include product repairs, maintenance services and technical support services that are typically delivered and recognized ratably over the contractual term. Our services business provides services to customers and partners to help maximize the performance of their investments in Oracle ... | Year Ended May 31,
(in millions)
2024
2023
2022
Cloud and license:
Revenues
$
44,464
$
41,086
$
36,052
Cloud services and license support expenses
8,783
7,222
4,915
Sales and marketing expenses
7,167
7,738
7,054
Margin (1)
$
28,514
$
26,126
$
24,083
Hardware:
Revenues
$
3,066
$
3,274
$
3,183
Hardware products and suppo... | https://www.sec.gov/Archives/edgar/data/1341439/000095017024075605/0000950170-24-075605-index.htm | 42 | true | 10-K|table_context|41+ | [
{
"fact_id": "f9d45e908c8f23bdb9ec1a5af77d57e5c668ed4990bbd85e13fe804ac0d0acef",
"concept": "us-gaap#RevenueFromContractWithCustomerExcludingAssessedTax",
"unit": "monetary:USD",
"period": "duration:2023-06-01..2024-05-31",
"value": "44464000000",
"displayed_text": "44,464",
"text_start"... | [
{
"span_text": "31,",
"start": 15,
"end": 18,
"class": "date"
},
{
"span_text": "2024",
"start": 33,
"end": 37,
"class": "year"
},
{
"span_text": "2023",
"start": 38,
"end": 42,
"class": "year"
},
{
"span_text": "2022",
"start": 43,
"end": 47,
... |
04c386d318604b27c779f61e56644232cbaa81b5a5d635edb942c44ac861fedb | 0001341439 | ORCL | ORACLE CORP | 7372 | 000095017024075605 | 10-K | 2024-06-20 | 2,024 | FY | notes | Remaining Performance Obligations from Contracts with Customers | ast transactions or other observable evidence. As a result, the SSP for a cloud license and an on-premise license included in a contract with multiple performance obligations is generally determined by applying a residual approach whereby all other performance obligations within a contract are first allocated a portion... | Trade receivables, net of allowance for credit losses, and deferred revenues are reported net of related uncollected deferred revenues in our consolidated balance sheets as of May 31, 2024 and 2023. The amount of revenues recognized during the year ended May 31, 2024 and 2023 that were included in the opening deferred ... | https://www.sec.gov/Archives/edgar/data/1341439/000095017024075605/0000950170-24-075605-index.htm | 6 | false | typed|6-15 | [
{
"fact_id": "f5a9053dca60c805b47761d70e6586979ade294bddea077b1e04779b15268805",
"concept": "us-gaap#ContractWithCustomerLiabilityRevenueRecognized",
"unit": "monetary:USD",
"period": "duration:2023-06-01..2024-05-31",
"value": "9000000000",
"displayed_text": "9.0",
"text_start": 400,
... | [
{
"span_text": "31,",
"start": 180,
"end": 183,
"class": "date"
},
{
"span_text": "2024",
"start": 184,
"end": 188,
"class": "year"
},
{
"span_text": "2023",
"start": 193,
"end": 197,
"class": "year"
},
{
"span_text": "31,",
"start": 259,
"end"... |
0044758c52284a98db2ca7b3a3615ce5c8efce99d3ac7939b9f243a2102b2860 | 0001856725 | RANI | RANI THERAPEUTICS HOLDINGS, INC. | 2834 | 000119312526226703 | 10-Q | 2026-05-15 | 2,026 | Q1 | table_context | null | ( 12 ) $ 43,181 | As of December 31, 2025
Amortized Cost
Unrealized Gains
Unrealized Losses
Estimated Fair Value
Current assets:
Cash equivalents:
Money market funds
$
6,757
$
—
$
—
$
6,757
U.S. Treasuries and agencies
6,891
—
—
6,891
Commercial paper
2,099
—
—
2,099
Corporate debt securities
1,491
—
—
1,491
Total cash equivalents
17,23... | https://www.sec.gov/Archives/edgar/data/1856725/000119312526226703/0001193125-26-226703-index.htm | 48 | false | 10-Q|table_context|41+ | [
{
"fact_id": "f7cb96efc199fd20450201abab7ac17d141022edbda353dfe94730113ea60620",
"concept": "us-gaap#AvailableForSaleDebtSecuritiesAmortizedCostBasis",
"unit": "monetary:USD",
"period": "instant:2025-12-31",
"value": "6757000",
"displayed_text": "6,757",
"text_start": 150,
"text_end"... | [
{
"span_text": "31,",
"start": 15,
"end": 18,
"class": "date"
},
{
"span_text": "2025",
"start": 19,
"end": 23,
"class": "year"
}
] |
003b3e726df203f92ee47a4d9e08c4e2f2cb360539b47e726b3bcca907a5ceee | 0001741530 | QFIN | Qfin Holdings, Inc. | 6199 | 000110465923050588 | 20-F | 2023-04-27 | 2,022 | FY | table_context | RMB | 12,983,458 Net income 2,541,386 5,462,150 2,443,983 | | Year ended
| Year ended
| Year ended
| December 31, 2020
| December 31, 2021
| December 31, 2022
| RMB
| RMB
| RMB
Net cash provided by operating activities
| 3,715,112
| 5,431,654
| 3,891,528
Net cash used in investing activities
| ( 1,012,415 )
| ( 1,427,958 )
| ( 6,750,277 )
Net cash (used in) provided by financin... | https://www.sec.gov/Archives/edgar/data/1741530/000110465923050588/qfin-20221231x20f.htm | 9 | false | 20-F|table_context|6-15 | [
{
"fact_id": "afdfff441e5e2c16a27fa36e0f85af3a089359c7f81f3ffd23dc0ee88b952600",
"concept": "us-gaap#NetCashProvidedByUsedInOperatingActivities",
"unit": "monetary:CNY",
"period": "duration:2020-01-01..2020-12-31",
"value": "3715112000",
"displayed_text": "3,715,112",
"text_start": 161,
... | [
{
"span_text": "31,",
"start": 50,
"end": 53,
"class": "date"
},
{
"span_text": "2020",
"start": 54,
"end": 58,
"class": "year"
},
{
"span_text": "31,",
"start": 70,
"end": 73,
"class": "date"
},
{
"span_text": "2021",
"start": 74,
"end": 78,
... |
004017d1550eaaf46c8d1e9dacd5a54225216eac5cc842e1d3cb5f4df08bb725 | 0001563577 | GRTX | Galera Therapeutics, Inc. | 2834 | 000095017022023516 | 10-Q | 2022-11-09 | 2,022 | Q3 | notes | NOTES TO UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS | Restricted cash represents collateral provided under a commercial credit card agreement entered into with TD Bank, N.A. during July 2022. Restricted cash was $ 50,000 as of September 30, 2022. The Company has recorded this deposit and accumulated interest thereon as restricted cash on its consolidated balance sheet. 7 ... | Research and development expenses
Research and development costs are expensed as incurred and consist primarily of funds paid to third parties for the provision of services for product candidate development, clinical and preclinical development and related supply and manufacturing costs, and regulatory compliance costs... | https://www.sec.gov/Archives/edgar/data/1563577/000095017022023516/0000950170-22-023516-index.htm | 2 | false | 10-Q|notes|2-5 | [
{
"fact_id": "608b404fc9ae9f29d1d51dc5032b3f34998559cc957f7c0160f4034628c89abf",
"concept": "ext-0001563577#IncreaseDecreaseInResearchAndDevelopmentExpense",
"unit": "monetary:USD",
"period": "duration:2022-01-01..2022-09-30",
"value": "300000",
"displayed_text": "0.3",
"text_start": 230... | [
{
"span_text": "2020,",
"start": 1851,
"end": 1856,
"class": "year"
},
{
"span_text": "1",
"start": 2033,
"end": 2034,
"class": "other"
},
{
"span_text": "30,",
"start": 2221,
"end": 2224,
"class": "date"
},
{
"span_text": "2021",
"start": 2225,
... |
0082b184748c050db467e5c6094ed3ee309c5108ce4211354dd366f4b30dc8fe | 0001654126 | ZIM | ZIM INTEGRATED SHIPPING SERVICES LTD. | 4412 | 000141057822000304 | 20-F | 2022-03-09 | 2,021 | FY | table_context | Impairment test | 7 Leases The Group is engaged in multiple lease arrangements for vessels and containers, supporting its operating activities, as well as for buildings, vehicles, IT equipment and other tangible assets. Such lease arrangements (part of which includes options for extension and / or purchase of the underlying asset) are c... | | Buildings, Vehicles
| Containers and
| and other tangible
| Vessels
| equipment
| assets
| Total
| US $’000
Balance as at January 1, 2021
| 826,678
| 466,070
| 47,911
| 1,340,659
Additions
| 1,677,501
| 85,171
| 16,273
| 1,778,945
Depreciation
| ( 602,100 )
| ( 89,158 )
| ( 18,502 )
| ( 709,760 )
Other (*)
| 818,135
... | https://www.sec.gov/Archives/edgar/data/0001654126/000141057822000304/tmb-20211231x20f.htm | 20 | false | 20-F|table_context|16-40 | [
{
"fact_id": "6456acb6ab5fe800ec2d936b308522402e2b333f982bf5e8656f39c501b85abc",
"concept": "ifrs#RightofuseAssets",
"unit": "monetary:USD",
"period": "instant:2020-12-31",
"value": "826678000",
"displayed_text": "826,678",
"text_start": 142,
"text_end": 149,
"dimensions": [
... | [
{
"span_text": "000",
"start": 106,
"end": 109,
"class": "date"
},
{
"span_text": "1,",
"start": 132,
"end": 134,
"class": "date"
},
{
"span_text": "2021",
"start": 135,
"end": 139,
"class": "year"
},
{
"span_text": "31,",
"start": 373,
"end": ... |
004349d8ca297015112b195ef5eb939e656c91a6933b90786a0ca7efe5208275 | 0000818479 | XRAY | DENTSPLY SIRONA Inc. | 3843 | 000081847920000052 | 10-Q | 2020-11-05 | 2,020 | Q3 | table_context | See accompanying Notes to Unaudited Interim Consolidated Financial Statements. (part 1) | $ 30.2 See accompanying Notes to Unaudited Interim Consolidated Financial Statements. 4 DENTSPLY SIRONA INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (in millions, except per share amounts) (unaudited) | |
| September 30, 2020 | December 31, 2019 |
Assets |
Current Assets: |
Cash and cash equivalents | $ | 1,272.0 | $ | 404.9 |
Accounts and notes receivables-trade, net | 628.1 | 782.0 |
Inventories, net | 489.1 | 561.7 |
Prepaid expenses and other current assets | 190.4 | 251.3 |
Total Current Assets | 2,579.6 | 1,999.... | https://www.sec.gov/Archives/edgar/data/818479/000081847920000052/xray-20200930.htm | 80 | true | 10-Q|table_context|41+ | [
{
"fact_id": "ef0b2315caf28936a077e14120d029ef36f22b29c8cc2b2a5485e3cfb5af6502",
"concept": "us-gaap#CashAndCashEquivalentsAtCarryingValue",
"unit": "monetary:USD",
"period": "instant:2020-09-30",
"value": "1272000000",
"displayed_text": "1,272.0",
"text_start": 104,
"text_end": 111,... | [
{
"span_text": "30,",
"start": 14,
"end": 17,
"class": "date"
},
{
"span_text": "2020",
"start": 18,
"end": 22,
"class": "year"
},
{
"span_text": "31,",
"start": 34,
"end": 37,
"class": "date"
},
{
"span_text": "2019",
"start": 38,
"end": 42,
... |
002c4dd5acc88f4fe74727430b207f8ffe20578ae80ef9960046f82dbe4b1e28 | 0001508478 | ARCO | Arcos Dorados Holdings Inc. | 5812 | 000162828022011552 | 20-F | 2022-04-29 | 2,021 | FY | notes | 12. Long-term debt (continued) | 0 and for each of the three years in the period ended December 31, 2021 Amounts in thousands of US dollars, except for share data and as otherwise indicated 12. Long-term debt (continued) 2027 and 2023 Notes (continued) On June 1, 2016, the Company launched a cash tender offer to purchase $ 80,000 of its outstanding 20... | On September 15, 2020 the Company launched an offer to exchange any and all of 2023 Notes for an additional issuance of 2027 Notes that expired on October 13, 2020 (the “expiration date”). The purpose of the exchange offer was to extend the maturity profile of the Company’s long-term debt. The settlement date was on Oc... | https://www.sec.gov/Archives/edgar/data/1508478/000162828022011552/arco-20211231.htm | 15 | true | 20-F|notes|6-15 | [
{
"fact_id": "b8da7477fac3a68f1dbdf7270c0bc503650ba4fe3fdd605990912fcb39c4ebed",
"concept": "ext-0001508478#DebtInstrumentSettlementAmount",
"unit": "monetary:USD",
"period": "duration:2020-09-27..2020-09-27",
"value": "1055000",
"displayed_text": "1,055",
"text_start": 477,
"text_en... | [
{
"span_text": "15,",
"start": 13,
"end": 16,
"class": "date"
},
{
"span_text": "2020",
"start": 17,
"end": 21,
"class": "year"
},
{
"span_text": "2023",
"start": 79,
"end": 83,
"class": "year"
},
{
"span_text": "2027",
"start": 120,
"end": 124... |
002522fe4a64e19050b2c801cec8a007209cdd3205934524372fa1ed70ed0cf6 | 0001621906 | WSTRF | WESTERN URANIUM & VANADIUM CORP. | 1090 | 000121390026056791 | 10-Q | 2026-05-14 | 2,026 | Q1 | notes | NOTE 8 – Related Party Transactions AND BALANCES | Company recorded the deferred contingent consideration as an assumed liability in the amount of $ 344,150 and $ 333,349 as of March 31, 2026 and December 31, 2025, respectively. The Company has multiple lease arrangements with Silver Hawk Ltd., an entity which is owned by George Glasier and his wife Kathleen Glasier. T... | The Company is obligated to pay Mr. Glasier for
reimbursable expenses in the amount of $ 8,124 and $ 74,063 , included within accounts payable and accrued liabilities, as of March 31, 2026
and December 31, 2025, respectively. | https://www.sec.gov/Archives/edgar/data/1621906/000121390026056791/0001213900-26-056791-index.htm | 2 | false | 10-Q|notes|2-5 | [
{
"fact_id": "2f96f152405dee3daa203c1249563887e46ba9f4ad4a1e56e5c8217d4216e2f5",
"concept": "us-gaap#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
"unit": "monetary:USD",
"period": "instant:2026-03-31",
"value": "8124",
"displayed_text": "8,124",
"text_start": 89,
"text_... | [
{
"span_text": "31,",
"start": 180,
"end": 183,
"class": "date"
},
{
"span_text": "2026",
"start": 184,
"end": 188,
"class": "year"
},
{
"span_text": "31,",
"start": 202,
"end": 205,
"class": "date"
},
{
"span_text": "2025,",
"start": 206,
"end... |
0396d9ff214cfdefabe3a8b83d6503bb059253ebbe0a1b74ad9f9b2b1c92d56b | 0001410384 | QTWO | Q2 Holdings, Inc. | 7372 | 000141038420000025 | 10-K | 2020-02-21 | 2,019 | FY | table_context | null | Table of Contents Q2 HOLDINGS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except per share amounts and unless otherwise indicated) 2019 common stock offering generated net proceeds to the Company of approximately $ 195.3 million , after deducting $ 8.2 million in underwriting discounts and commissio... | |
| Year Ended December 31,
| 2018
| 2017
Risk-free interest rate
| 2.6 %
| 1.7 - 2.1%
Expected life (in years)
| 4.8
| 4.8
Expected volatility
| 41.0 %
| 41.5 - 43.1%
Dividend yield
| —
| —
Weighted-average grant date fair value per share
| $ 18.14
| $ 14.17 | https://www.sec.gov/Archives/edgar/data/1410384/000141038420000025/a191231qtwo10k.htm | 6 | true | 10-K|table_context|6-15 | [
{
"fact_id": "f4a3a291cac34409a38011ec31beaca4c3267555f708eb52e15376745eb2e243",
"concept": "us-gaap#ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
"unit": "pure",
"period": "duration:2018-01-01..2018-12-31",
"value": "0.026",
"displayed_t... | [
{
"span_text": "31,",
"start": 24,
"end": 27,
"class": "date"
},
{
"span_text": "2018",
"start": 30,
"end": 34,
"class": "year"
},
{
"span_text": "2017",
"start": 37,
"end": 41,
"class": "year"
},
{
"span_text": "1.7",
"start": 76,
"end": 79,
... |
00e393025a15dab7163d29d5ab1bc4cc0183d96b5ae9f7ee06d9ce05bc99b2a6 | 0001819989 | CIFR | CIPHER MINING INC. | 6199 | 000095017021004222 | 10-Q | 2021-11-12 | 2,021 | Q3 | table_context | Three Months Ended September 30, 2021 | The accompanying notes are an integral part of these unaudited condensed consolidated financial statements 5 CIPHER MINING INC. CONDENSED CONSOLIDATED STATEMENTS OF CHAN GES IN STOCKHOLDERS’ EQUITY (DEFICIT) (Unaudited) Three Months Ended September 30, 2021 | Common Stock
Total
Shares
Amount
Subscription Receivable
Additional Paid-in Capital
Accumulated deficit
Stockholders' Equity (Deficit)
Balance as of June 30, 2021
500
$
1
$
-
$
4
$
( 664,249
)
$
( 664,244
)
Retroactive application of recapitalization
199,999,500
199,999
-
( 199,999
)
-
-
Balance as of June 30, 2021, af... | https://www.sec.gov/Archives/edgar/data/1819989/000095017021004222/0000950170-21-004222-index.htm | 27 | false | 10-Q|table_context|16-40 | [
{
"fact_id": "eccea45bc58a0ecf2b17ddebfc5b92b17c11e94ee3d9ed40470c3a0f02022cb5",
"concept": "us-gaap#SharesOutstanding",
"unit": "shares",
"period": "instant:2021-06-30",
"value": "500",
"displayed_text": "500",
"text_start": 163,
"text_end": 166,
"dimensions": [
{
... | [
{
"span_text": "30,",
"start": 154,
"end": 157,
"class": "date"
},
{
"span_text": "2021",
"start": 158,
"end": 162,
"class": "year"
},
{
"span_text": "30,",
"start": 308,
"end": 311,
"class": "date"
},
{
"span_text": "2021,",
"start": 312,
"end... |
004c2d45bcc06362465628cd63bb1d3f34ff9648b070ebb9af4a968b83ef8455 | 0001389050 | AROC | Archrock, Inc. | 4922 | 000138905020000028 | 10-K | 2020-02-21 | 2,019 | FY | table_context | Unaudited Pro Forma Financial Information | quisition; and • the exclusion of $ 7.8 million of financial advisory, legal and other professional fees incurred related to the acquisition and recorded to transaction-related costs in our consolidated statements of operations during the year ended December 31, 2019 . The unaudited pro forma financial information belo... | |
| Year Ended December 31,
| 2019
| 2018
Revenue
| $
| 1,009,763
| $
| 977,929
Net income attributable to Archrock stockholders
| 106,521
| 24,566 | https://www.sec.gov/Archives/edgar/data/1389050/000138905020000028/a201910karoc.htm | 4 | true | 10-K|table_context|2-5 | [
{
"fact_id": "2ca93a0ca6fed4ce153c0167af55a0a11e41c3486158f37fd9befe8395c4411d",
"concept": "us-gaap#BusinessAcquisitionsProFormaRevenue",
"unit": "monetary:USD",
"period": "duration:2019-01-01..2019-12-31",
"value": "1009763000",
"displayed_text": "1,009,763",
"text_start": 56,
"tex... | [
{
"span_text": "31,",
"start": 24,
"end": 27,
"class": "date"
},
{
"span_text": "2019",
"start": 30,
"end": 34,
"class": "year"
},
{
"span_text": "2018",
"start": 37,
"end": 41,
"class": "year"
}
] |
00e53752199d35df71dbfa59d68a008c1e0a36b51e5014f9f873f29637875bad | 0001429260 | FBIO | Fortress Biotech, Inc. | 2834 | 000155837025004160 | 10-K | 2025-03-31 | 2,024 | FY | table_context | null | an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity and ASC 815-40, Derivatives and Hedging - Contracts in Entity’s Own Equity . For warrants that meet all of the criteria for equity classification, the warrants are required to be record... | | Warrants
($ in thousands)
| liabilities
Balance at December 31, 2022
| $
| 13,869
Avenue common stock warrants
| 2,235
Urica placement agent warrants
| 33
Change in fair value of common stock warrants - Avenue
| ( 4,258 )
Change in fair value of common stock warrants - Checkpoint
| ( 7,924 )
Change in fair value of p... | https://www.sec.gov/Archives/edgar/data/0001429260/000155837025004160/fbio-20241231x10k.htm | 14 | true | 10-K|table_context|6-15 | [
{
"fact_id": "d43dd114282f03712602893c8d829c3501e890a1a8f704032022df166b6ef604",
"concept": "ext-0001429260#WarrantLiabilitiesCurrent",
"unit": "monetary:USD",
"period": "instant:2022-12-31",
"value": "13869000",
"displayed_text": "13,869",
"text_start": 77,
"text_end": 83,
"dime... | [
{
"span_text": "31,",
"start": 62,
"end": 65,
"class": "date"
},
{
"span_text": "2022",
"start": 66,
"end": 70,
"class": "year"
},
{
"span_text": "31,",
"start": 436,
"end": 439,
"class": "date"
},
{
"span_text": "2023",
"start": 440,
"end": 44... |
00a3196c5ce61c93e2cbe540e017eb7f7cca40600e8b3f7ca2c93a607d3dc5ea | 0001601485 | ELTX | ANGION BIOMEDICA CORP | 2834 | 000160148526000042 | 10-Q | 2026-05-11 | 2,026 | Q1 | notes | January 2025 Offering | the Company issued and sold 119,479 shares of common stock at a weighted average price of $ 11.42 per share under the 2026 ATM Program for net proceeds of approximately $ 1.3 million after deducting sales commissions. The Company incurred offering costs of $ 0.2 million related to the initial setup of the 2026 ATM Prog... | In January 2025, the Company closed the January 2025 Offering, pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors, the January 2025 Shares and January 2025 Common Warrants. For clarity, the January 2025 Shares consist of 1,261,830 shares of c... | https://www.sec.gov/Archives/edgar/data/1601485/000160148526000042/0001601485-26-000042-index.htm | 5 | true | 10-Q|notes|2-5 | [
{
"fact_id": "aaf0a17367b105f7bcf64da2bad1cf9d6c6ae40d8e70749ec5407a04e9f9f47d",
"concept": "us-gaap#SaleOfStockNumberOfSharesIssuedInTransaction",
"unit": "shares",
"period": "duration:2025-01-01..2025-01-31",
"value": "1261830",
"displayed_text": "1,261,830",
"text_start": 299,
"te... | [
{
"span_text": "2025,",
"start": 11,
"end": 16,
"class": "year"
},
{
"span_text": "2025",
"start": 48,
"end": 52,
"class": "year"
},
{
"span_text": "2025",
"start": 205,
"end": 209,
"class": "year"
},
{
"span_text": "2025",
"start": 229,
"end":... |
0060bc5ce84aa5dce1079929488a8610c7a89536829a1f1acc4b535847c33992 | 0000932781 | FCCO | FIRST COMMUNITY CORPORATION | 6022 | 000155278125000082 | 10-K | 2025-03-14 | 2,024 | FY | notes | HELD-TO-MATURITY: | 490 $ 487 Due after one year through five years 15,045 14,634 Due after five years through ten years 33,167 29,179 Due after ten years 250,835 235,282 $ 299,537 $ 279,582 HELD-TO-MATURITY: (Dollars in thousands) Held-to-maturity Amortized Cost Fair Value Due in one year or less $ 7,284 $ 7,234 Due after one year throug... | Securities with
an amortized cost of $3 88.5 million and fair value of $ 363.8 million at December 31, 2024 were pledged to secure FHLB advances,
public deposits, and securities sold under agreements to repurchase. Securities with an amortized cost of $ 160.8 million and fair
value of $ 150.6 million at December 31, 20... | https://www.sec.gov/Archives/edgar/data/0000932781/000155278125000082/e25084_fcco-10k.htm | 4 | true | 10-K|notes|2-5 | [
{
"fact_id": "f1e0dca4185a3eca49ea0674b8eb9a1c1e7f0d62085f2791e257edb33b60d5f1",
"concept": "ext-0000932781#SecurityOwnedAndPledgedAsCollateralAmortizedCost",
"unit": "monetary:USD",
"period": "instant:2024-12-31",
"value": "88500000",
"displayed_text": "88.5",
"text_start": 40,
"tex... | [
{
"span_text": "$3",
"start": 37,
"end": 39,
"class": "untagged_amount"
},
{
"span_text": "31,",
"start": 99,
"end": 102,
"class": "date"
},
{
"span_text": "2024",
"start": 103,
"end": 107,
"class": "year"
},
{
"span_text": "31,",
"start": 314,
... |
02020630bd94f57592bb86c200c90e300c2adf5c1e0b17665d21450eac1a479c | 0001372807 | BCIC | Portman Ridge Finance Corporation | null | 000095017023061092 | 10-Q | 2023-11-08 | 2,023 | Q3 | table_context | Equity Securities Portfolio (part 2) | 43 See accompanying notes to unaudited consolidated financial statements. 18 Equity Securities Portfolio | Portfolio Company 14
Investment
Industry
Interest Rate
Initial Acquisition Date
Par/Shares
Cost
Fair Value 2
Footnote Refs
4L Ultimate Topco Corporation
Common
Services: Business
5/29/20
321
$
29
$
29
(7)(12)(18)
AAPC Holdings, LLC
Equity
Services: Consumer
5/18/22
-
-
280
(7)(12)(18)(23)
AAPC Holdings, LLC
Preferred E... | https://www.sec.gov/Archives/edgar/data/0001372807/000095017023061092/ptmn-20230930.htm | 97 | false | typed|41+ | [
{
"fact_id": "da83dc9bce8af55e36979582fb068bfaac53a228be4271141a7fd5def42160d0",
"concept": "us-gaap#InvestmentOwnedBalanceShares",
"unit": "shares",
"period": "instant:2022-12-31",
"value": "321000",
"displayed_text": "321",
"text_start": 187,
"text_end": 190,
"dimensions": [
... | [
{
"span_text": "14",
"start": 18,
"end": 20,
"class": "untagged_amount"
},
{
"span_text": "2",
"start": 107,
"end": 108,
"class": "other"
},
{
"span_text": "4",
"start": 123,
"end": 124,
"class": "other"
},
{
"span_text": "5",
"start": 179,
"en... |
0037c0940b40929b12dc71bbb557a73d00a7591c714fc1969ccff8c1874c070d | 0000858470 | CTRA | CABOT OIL & GAS CORPORATION | 1311 | 000085847025000075 | 10-K | 2025-02-25 | 2,024 | FY | mda | 4. Long-Term Debt and Credit Agreements | 17,933 Capitalized Exploratory Well Costs As of and for the years ended December 31, 2024, 2023 and 2022, the Company did not have any projects with exploratory well costs capitalized for a period of greater than one year after drilling. 67 Table of Contents 4. Long-Term Debt and Credit Agreements | The following table includes a summary of the Company’s long-term debt.
| December 31, |
(In millions) | 2024 | 2023 |
Private placement senior notes: |
3.65 % weighted-average private placement senior notes (1)
| $ | 250 | $ | 825 |
Senior notes: |
3.90 % senior notes due May 15, 2027
| 750 | 750 |
4.375 % senior note... | https://www.sec.gov/Archives/edgar/data/858470/000085847025000075/cog-20241231.htm | 38 | true | 10-K|mda|16-40 | [
{
"fact_id": "ce398aaea3ca67a8d833aca0f39624973992168314ee6bb64ac3f4bb1b2bf13f",
"concept": "us-gaap#LongtermDebtWeightedAverageInterestRate",
"unit": "pure",
"period": "instant:2024-12-31",
"value": "0.0365",
"displayed_text": "3.65",
"text_start": 153,
"text_end": 157,
"dimensi... | [
{
"span_text": "31,",
"start": 83,
"end": 86,
"class": "date"
},
{
"span_text": "2024",
"start": 105,
"end": 109,
"class": "year"
},
{
"span_text": "2023",
"start": 112,
"end": 116,
"class": "year"
},
{
"span_text": "(1)",
"start": 208,
"end": ... |
008fd422f091f9f3d71a8216e8de0c39c826aa2d46fae889e62196ad3b7161fa | 0001872292 | RAKR | RAINMAKER WORLDWIDE INC. | 2086 | 000149315223044284 | 10-Q | 2023-12-08 | 2,023 | Q3 | table_context | Derivative liabilities (fair value) | 273,679 . On December 31, 2022, a gain on derivative liabilities was recognized in the amount of $ 229,355 leaving a fair value at December 31, 2022 of $ 44,324 for warrants. On September 30, 2023, a loss on derivative liabilities was recognized in the amount of $ 3,794 leaving a fair value of $ 2,552 for warrants at S... | Beginning Balance |
$ | 502,611 |
Change due to Issuances |
| 108,440 |
Change due to Conversions |
| ( 194,151 | ) |
Mark-to-market |
| ( 134,574 | ) |
Ending Balance |
$ | 282,326 | | https://www.sec.gov/Archives/edgar/data/0001872292/000149315223044284/form10-q.htm | 5 | false | 10-Q|table_context|2-5 | [
{
"fact_id": "070c0faae87da9f330ac464d06b3e719333e42303c970cd81eaf7737fcb2e2d8",
"concept": "us-gaap#DerivativeLiabilitiesCurrent",
"unit": "monetary:USD",
"period": "instant:2022-12-31",
"value": "502611",
"displayed_text": "502,611",
"text_start": 24,
"text_end": 31,
"dimension... | [] |
004c1ecf9c066f5341679c1077f121d251c310c3ed720e2566ae2da5921937a3 | 0001908984 | ENDI | ENDI Corp. | 6282 | 000149315223040471 | 10-Q | 2023-11-13 | 2,023 | Q3 | table_context | null | $ 20,378,618 $ 1,485,958 $ 21,865,121 | Common
Stock |
Amount |
Additional
Paid-in Capital |
Retained
Earnings |
Total
Stockholders’ Equity |
Balance
December 31, 2021 |
| 2,400,000 |
$ | 240 |
$ | - |
$ | 591,669 |
$ | 591,909 |
Net
income |
| - |
| - |
| - |
| 761,617 |
| 761,617 |
Balance
March 31, 2022 |
| 2,400,000 |
| 240 |
| - |
| 1,353,286 |
| 1,353,... | https://www.sec.gov/Archives/edgar/data/0001908984/000149315223040471/form10-q.htm | 35 | false | 10-Q|table_context|16-40 | [
{
"fact_id": "2c2a85067c33397e5226dd8b8470b19945144ce79988644d9d2c95dd033a18b6",
"concept": "us-gaap#SharesOutstanding",
"unit": "shares",
"period": "instant:2021-12-31",
"value": "2400000",
"displayed_text": "2,400,000",
"text_start": 132,
"text_end": 141,
"dimensions": [
... | [
{
"span_text": "31,",
"start": 119,
"end": 122,
"class": "date"
},
{
"span_text": "2021",
"start": 123,
"end": 127,
"class": "year"
},
{
"span_text": "31,",
"start": 259,
"end": 262,
"class": "date"
},
{
"span_text": "2022",
"start": 263,
"end"... |
003727b0d0a022aaa176cc6e011af4cac462181053e788270effd0258edfcfba | 0001530950 | POST | Post Holdings, Inc. | 2040 | 000153095023000057 | 10-Q | 2023-02-03 | 2,023 | Q1 | notes | NOTE 15 — LONG-TERM DEBT | vailable at law or under the loan documents, including with respect to the collateral and guarantees of the Company’s obligations under the Credit Agreement. Municipal Bond In connection with the construction of a filtration system at the Company’s potato plant in Chaska, Minnesota, the Company incurred debt that guara... | The following table presents the Company’s cash repayments of debt, net of discounts included in the Condensed Consolidated Statement of Cash Flows and the associated gain included in “Gain on extinguishment of debt, net” in the Condensed Consolidated Statement of Operations during the three months ended December 31, 2... | https://www.sec.gov/Archives/edgar/data/1530950/000153095023000057/post-20221231.htm | 18 | false | 10-Q|notes|16-40 | [
{
"fact_id": "92fedf1d3bf92efb0191889c24b90e79442b3d34829fbbaa18570b44f1ca2a25",
"concept": "ext-0001530950#GrossRepaymentsofLongtermdebt",
"unit": "monetary:USD",
"period": "duration:2022-10-01..2022-12-31",
"value": "71000000",
"displayed_text": "71.0",
"text_start": 606,
"text_end... | [
{
"span_text": "31,",
"start": 315,
"end": 318,
"class": "date"
},
{
"span_text": "2022",
"start": 319,
"end": 323,
"class": "year"
},
{
"span_text": "31,",
"start": 402,
"end": 405,
"class": "date"
},
{
"span_text": "2021",
"start": 406,
"end"... |
0423e8cc646329d7a57b6e3a074b15514e315982f5a60c60be0f81ee616d9c46 | 0001828972 | BZFD | BuzzFeed, Inc. | 4899 | 000182897226000056 | 10-Q | 2026-05-11 | 2,026 | Q1 | table_context | (Unaudited, in thousands) | ) $ ( 12,343 ) The accompanying notes are an integral part of these condensed consolidated financial statements. 7 Table of Contents BUZZFEED, INC. CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited, in thousands) | For the Three Months Ended March 31, 2026 |
Common Stock – Class A | Common Stock – Class B | Treasury Stock | Additional paid-in capital | Accumulated deficit | Accumulated other comprehensive loss | Total BuzzFeed, Inc. stockholders’ equity | Noncontrolling interests | Total stockholders’ equity |
Shares | Amount | S... | https://www.sec.gov/Archives/edgar/data/0001828972/000182897226000056/bzfd-20260331.htm | 38 | true | 10-Q|table_context|16-40 | [
{
"fact_id": "9b3042c7c44b44f28831585a0408db93bf8a829981eed542d0d70add94c5bffc",
"concept": "us-gaap#CommonStockSharesOutstanding",
"unit": "shares",
"period": "instant:2025-12-31",
"value": "37857000",
"displayed_text": "37,857",
"text_start": 366,
"text_end": 372,
"dimensions":... | [
{
"span_text": "31,",
"start": 33,
"end": 36,
"class": "date"
},
{
"span_text": "2026",
"start": 37,
"end": 41,
"class": "year"
},
{
"span_text": "1,",
"start": 356,
"end": 358,
"class": "date"
},
{
"span_text": "2026",
"start": 359,
"end": 363... |
038ea980b25bb32683ecd9bc3fd754612a8215a1dc391977bec7ba0dc7d4ab24 | 0000717806 | FUSB | FIRST US BANCSHARES, INC | 6022 | 000095017025039251 | 10-K | 2025-03-14 | 2,024 | FY | notes | FIRST US BANCSHARES, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) | December 31, 2023 (Dollars in Thousands) Operating lease income (1) Lease income $ 1,033 $ 949 Operating lease expense (2) Net occupancy and equipment $ 565 $ 460 (1) Operating lease income includes rental income from owned properties. (2) Includes short-term lease costs. For the years ended December 31, 2024 and 2023 ... | The following table provides supplemental lease information for operating leases on the consolidated balance sheets as of December 31, 2024 and 2023:
Location
December 31, 2024
December 31, 2023
(Dollars in Thousands)
(Dollars in Thousands)
Operating lease right-of-use assets
Other assets
$
1,921
$
2,019
Operating leas... | https://www.sec.gov/Archives/edgar/data/0000717806/000095017025039251/fusb-20241231.htm | 17 | true | 10-K|notes|16-40 | [
{
"fact_id": "644690f238f3748ceba1459d29e5b1bdbf093ee46871db44ff901528d18c6b8e",
"concept": "us-gaap#OperatingLeaseRightOfUseAsset",
"unit": "monetary:USD",
"period": "instant:2024-12-31",
"value": "1921000",
"displayed_text": "1,921",
"text_start": 292,
"text_end": 297,
"dimensi... | [
{
"span_text": "31,",
"start": 131,
"end": 134,
"class": "date"
},
{
"span_text": "2024",
"start": 135,
"end": 139,
"class": "year"
},
{
"span_text": "2023",
"start": 144,
"end": 148,
"class": "year"
},
{
"span_text": "31,",
"start": 168,
"end"... |
00b62161609a02d3e9627a5ad9786913cb9f9bec3fc17772a28c8d3daeb6588b | 0001065078 | NTIP | NETWORK-1 TECHNOLOGIES, INC. | 6794 | 000107261325000187 | 10-K | 2025-02-28 | 2,024 | FY | table_context | Note G – Marketable Securities | 121,000 and $ 99,000 , respectively, accrued for dividend equivalent rights which were included in other accrued expenses. F-16 NETWORK-1 TECHNOLOGIES, INC. Note G – Marketable Securities Marketable securities as of December 31, 2024 and 2023 were composed of: | December 31, 2024 |
Cost
Basis |
Gross
Unrealized Gains |
Gross
Unrealized Losses |
Fair
Value |
Government
securities
$ | 16,470,000 |
$ | 63,000 |
$ | ( 71,000 | ) |
$ | 16,462,000 |
Fixed
income mutual funds |
| 9,630,000 |
| 132,000 |
| ( 30,000 | ) |
| 9,732,000 |
Certificates
of deposit |
| 752,000 |
| 9,000 |
| ... | https://www.sec.gov/Archives/edgar/data/1065078/000107261325000187/0001072613-25-000187-index.htm | 32 | false | 10-K|table_context|16-40 | [
{
"fact_id": "02f46f792b274aa27f7ad5b9ea5fe298517bce99d33152020d5374af54fa4680",
"concept": "ext-0001065078#GovernmentSecurities",
"unit": "monetary:USD",
"period": "instant:2024-12-31",
"value": "16470000",
"displayed_text": "16,470,000",
"text_start": 123,
"text_end": 133,
"dim... | [
{
"span_text": "31,",
"start": 9,
"end": 12,
"class": "date"
},
{
"span_text": "2024",
"start": 13,
"end": 17,
"class": "year"
},
{
"span_text": "31,",
"start": 509,
"end": 512,
"class": "date"
},
{
"span_text": "2023",
"start": 513,
"end": 517... |
00598d2eafc29779d9b088242b0b40ff0172f9eda0d48eb67140e94354d7a9d3 | 0001050915 | PWR | Quanta Services, Inc. | 1731 | 000105091524000009 | 10-K | 2024-02-22 | 2,023 | FY | notes | 12. INCOME TAXES: | RVICES, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - ( Continued ) The weighted average remaining lease terms and discount rates were as follows: As of December 31, 2023 2022 Weighted average remaining lease term (in years): Operating leases 4.34 4.39 Finance leases 5.69 2.93 Weighted average disc... | The components of income before income taxes were as follows (in thousands):
| Year Ended December 31, |
| 2023 | 2022 | 2021 |
Income before income taxes: |
Domestic | $ | 823,691 | $ | 532,051 | $ | 534,302 |
Foreign | 146,265 | 171,835 | 88,599 |
Total | $ | 969,956 | $ | 703,886 | $ | 622,901 |
The components of th... | https://www.sec.gov/Archives/edgar/data/1050915/000105091524000009/pwr-20231231.htm | 42 | true | 10-K|notes|41+ | [
{
"fact_id": "29f3b8dd6c6560c92c0863cd1802a0eefe897bb5e84fca06ff354e474e4e94b8",
"concept": "us-gaap#IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
"unit": "monetary:USD",
"period": "duration:2023-01-01..2023-12-31",
"value": "823691000",
"displayed_text": "823,691",
"text... | [
{
"span_text": "31,",
"start": 99,
"end": 102,
"class": "date"
},
{
"span_text": "2023",
"start": 107,
"end": 111,
"class": "year"
},
{
"span_text": "2022",
"start": 114,
"end": 118,
"class": "year"
},
{
"span_text": "2021",
"start": 121,
"end"... |
004332b39781463ffcf9a4a972ff4ab15eee16477ba89b1212cbb40af94d62e2 | 0001559865 | EVTC | EVERTEC, Inc. | 7374 | 000162828020007260 | 10-Q | 2020-05-11 | 2,020 | Q1 | notes | Note 10 - Revenues | g period in 2019 . As of March 31, 2020 , the maximum unrecognized cost for restricted stock and RSUs was $ 26.3 million . The cost is expected to be recognized over a weighted average period of 2.3 years. Note 10 - Revenues Disaggregation of Revenue | The Company disaggregates revenue from contracts with customers into primary geographical markets, nature of the products and services, and timing of transfer of goods and services. The Company's operating segments are determined by the nature of the products and services the Company provides and the primary geographic... | https://www.sec.gov/Archives/edgar/data/1559865/000162828020007260/0001628280-20-007260-index.htm | 30 | true | 10-Q|notes|16-40 | [
{
"fact_id": "069f45f6ed4e4af25059151a6a4353eb6140d424007557b8e8e07e6f49b5058d",
"concept": "us-gaap#RevenueFromContractWithCustomerExcludingAssessedTax",
"unit": "monetary:USD",
"period": "duration:2020-01-01..2020-03-31",
"value": "5000",
"displayed_text": "5",
"text_start": 864,
"... | [
{
"span_text": "15,",
"start": 416,
"end": 419,
"class": "note_ref"
},
{
"span_text": "13",
"start": 568,
"end": 570,
"class": "untagged_amount"
},
{
"span_text": "31,",
"start": 616,
"end": 619,
"class": "date"
},
{
"span_text": "2020",
"start": 6... |
0047a009dcc56f496ee85caa4793112e2a74f049beb107293cc6d6c314c5c143 | 0001676238 | BRZE | Braze, Inc. | 7372 | 000167623823000209 | 10-Q | 2023-12-07 | 2,024 | Q3 | notes | Contract Balances | $ 256,751 Revenue by geography is determined based on the location of our users. Other than the United States, no other individual country accounted for 10% or more of total revenue for any of the periods presented. Unbilled Accounts Receivable Unbilled accounts receivable included in trade accounts receivable, net, wh... | Contract assets as of October 31, 2023 and January 31, 2023 were $ 0.3 million and $ 0.8 million, respectively. The change in contract assets for all periods presented primarily reflects revenue recognized in excess of billings partially offset by contract assets earned during the period.
Deferred Revenue
The change in... | https://www.sec.gov/Archives/edgar/data/1676238/000167623823000209/0001676238-23-000209-index.htm | 6 | false | 10-Q|notes|6-15 | [
{
"fact_id": "a503a90e069c3edccaf15ceacb7939bee068c55a70cc7e77cfbda2a37277f146",
"concept": "us-gaap#ContractWithCustomerAssetGross",
"unit": "monetary:USD",
"period": "instant:2023-10-31",
"value": "300000",
"displayed_text": "0.3",
"text_start": 67,
"text_end": 70,
"dimensions"... | [
{
"span_text": "31,",
"start": 30,
"end": 33,
"class": "date"
},
{
"span_text": "2023",
"start": 34,
"end": 38,
"class": "year"
},
{
"span_text": "31,",
"start": 51,
"end": 54,
"class": "date"
},
{
"span_text": "2023",
"start": 55,
"end": 59,
... |
009f614ccd9e52a0bc68d7ebafac3e4a59dd2e9d482924355789ac6bfe580fe5 | 0001961847 | INHD | INNO HOLDINGS INC. | 5990 | 000164117225008269 | 10-Q | 2025-05-02 | 2,025 | Q2 | table_context | Note 4 — Prepayments and other current assets | As of March 31, 2025 and September 30, 2024, there was no allowance for obsolescence recorded. 11 Note 4 — Prepayments and other current assets As of March 31, 2025 and September 30, 2024, prepayments and other current assets consisted of the following: | March 31,
2025
September 30,
2024
(unaudited) |
Prepaid marketing and promotional services |
$ | 100,000 |
$ | — |
Prepaid for software development |
| 125,000 |
| — |
Advance to suppliers |
| 120,000 |
Prepaid insurance |
| — |
| 35,172 |
Prepaid for consulting services |
| 159,028 |
| — |
Loan receivable |
| 500,000 ... | https://www.sec.gov/Archives/edgar/data/0001961847/000164117225008269/form10-q.htm | 11 | false | 10-Q|table_context|6-15 | [
{
"fact_id": "ce99f99472c37bd6af6ea24f470de56f85703721c1a014b73eda0507a560ae88",
"concept": "us-gaap#PrepaidAdvertising",
"unit": "monetary:USD",
"period": "instant:2025-03-31",
"value": "100000",
"displayed_text": "100,000",
"text_start": 97,
"text_end": 104,
"dimensions": [],
... | [
{
"span_text": "31,",
"start": 6,
"end": 9,
"class": "date"
},
{
"span_text": "2025",
"start": 10,
"end": 14,
"class": "year"
},
{
"span_text": "30,",
"start": 25,
"end": 28,
"class": "date"
},
{
"span_text": "2024",
"start": 29,
"end": 33,
... |
003fed488663f84c5f1be51d2e8a25dd8844c939203c00c8bf5dc1f86c85c11f | 0001495153 | MMYT | MakeMyTrip Ltd | 4700 | 000095017023034278 | 20-F | 2023-07-25 | 2,023 | FY | notes | (Amounts in USD thousands, except per share data and share count) | 30,000 in aggregate principal amount of the Notes issued pursuant to the full exercise of the initial purchasers’ option to purchase additional Notes. F- 53 MAKEMYTRIP LIMITED NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS– (Continued) (Amounts in USD thousands, except per share data and share count) | The Notes are convertible based upon an initial conversion rate of 25.8035 of the Company’s ordinary shares, par value USD 0.0005 per share (the “ordinary shares”) per USD 1,000 principal amount of Notes (equivalent to a conversion price of approximately USD 38.75 per ordinary share). The Notes will mature on February ... | https://www.sec.gov/Archives/edgar/data/1495153/000095017023034278/mmyt-20230331.htm | 7 | true | 20-F|notes|6-15 | [
{
"fact_id": "486d70ee93109a65a73fce04452d619673f898f5ad00417ba74165a880a7882f",
"concept": "ext-0001495153#InitialConversionRate",
"unit": "pure",
"period": "duration:2021-02-09..2021-02-09",
"value": "25.8035",
"displayed_text": "25.8035",
"text_start": 67,
"text_end": 74,
"dim... | [
{
"span_text": "15,",
"start": 320,
"end": 323,
"class": "date"
},
{
"span_text": "2028",
"start": 324,
"end": 328,
"class": "year"
},
{
"span_text": "15,",
"start": 606,
"end": 609,
"class": "date"
},
{
"span_text": "2028",
"start": 610,
"end"... |
00af8500c226c0af9a1a82db6f39706fec49a0cd2cc12cfde011dc68ae215d71 | 0001374339 | PMN | PROMIS NEUROSCIENCES INC. | 2834 | 000110465926059035 | 10-Q | 2026-05-12 | 2,026 | Q1 | notes | Consolidated Net Loss: | nologies. The agreements require compensation to be paid by the Company, typically, by a combination of the following: ● fees comprising amounts due initially on entering into the agreements and additional amounts due either on specified timelines or defined services to be provided; ● milestone payments that are depend... | Milestone and royalty related amounts that may come due under various agreements are dependent on, among other factors, preclinical safety and efficacy, clinical trials, regulatory approvals and, ultimately, the successful development and commercial launch of a new drug, the outcomes and timings of which are uncertain.... | https://www.sec.gov/Archives/edgar/data/0001374339/000110465926059035/pmn-20260331x10q.htm | 4 | false | 10-Q|notes|2-5 | [
{
"fact_id": "32efae7154e0857b004492966dda693bf4eed5a37f29201b242aedd203615a3d",
"concept": "ext-0001374339#CollaborativeArrangementAccrualsForRoyaltyPayments",
"unit": "monetary:USD",
"period": "instant:2026-03-31",
"value": "0",
"displayed_text": "no",
"text_start": 561,
"text_end"... | [
{
"span_text": "31,",
"start": 551,
"end": 554,
"class": "date"
},
{
"span_text": "2026,",
"start": 555,
"end": 560,
"class": "year"
},
{
"span_text": "2016,",
"start": 717,
"end": 722,
"class": "year"
},
{
"span_text": "2022,",
"start": 880,
"... |
0138d8f095d85cc0772f1df3d5bb30c245aa38681c664c7cb4bd31e9434bcee3 | 0001410428 | XWEL | XWELL, Inc. | 7200 | 000110465926064495 | 10-Q | 2026-05-20 | 2,026 | Q1 | table_context | null | receivable, and accounts payable approximated their fair values as of March 31, 2026 due to their short-term nature. The fair value of the bifurcated embedded derivative related to the convertible preferred stock and Note was estimated using a Monte Carlo simulation model, which uses as inputs the fair value of our com... | | Fair value measurement at reporting date using
| Quoted prices in
| active markets
| Significant other
| Significant
| for identical
| observable
| unobservable
| Balance
| assets (Level 1)
| inputs (Level 2)
| inputs (Level 3)
As of March 31, 2026:
Recurring fair value measurements
Equity and debt securities:
Route1... | https://www.sec.gov/Archives/edgar/data/1410428/000110465926064495/0001104659-26-064495-index.htm | 33 | false | 10-Q|table_context|16-40 | [
{
"fact_id": "91758d5a29729331da04c06df075c95b07f26c16a10dfd83069a3e1858459005",
"concept": "us-gaap#EquitySecuritiesFvNi",
"unit": "monetary:USD",
"period": "instant:2026-03-31",
"value": "90000",
"displayed_text": "90",
"text_start": 333,
"text_end": 335,
"dimensions": [
... | [
{
"span_text": "1)",
"start": 189,
"end": 191,
"class": "note_ref"
},
{
"span_text": "2)",
"start": 208,
"end": 210,
"class": "note_ref"
},
{
"span_text": "3)",
"start": 227,
"end": 229,
"class": "date"
},
{
"span_text": "31,",
"start": 242,
"e... |
00cdb3b0b6bc219ddd132f14cd3b20acf1861f4994586ca91cec7273fa998d2d | 0000946563 | RVP | Retractable Technologies, Inc | 3841 | 000155837024012200 | 10-Q | 2024-08-14 | 2,024 | Q2 | table_context | null | $ — $ — $ 34,621,213 The investment assets are held as trading securities and are carried at fair value as of the date of the Condensed Balance Sheets. The Company intends to hold these assets for possible future operating requirements. The following table summarizes gross unrealized gains and losses from Investments i... | | June 30, 2024
| Cumulative Unrealized
| Aggregate
| Cost
| Gains
| Losses
| Fair Value
Equity securities
| $
| 24,151,932
| —
| ( 5,828,529 )
| 18,323,403
Mutual funds
| 15,975,653
| 83,775
| —
| 16,059,428
Municipal bonds
| 635,929
| 32,739
| —
| 668,668
| $
| 40,763,514
| $
| 116,514
| $
| ( 5,828,529 )
| $
| 35,05... | https://www.sec.gov/Archives/edgar/data/0000946563/000155837024012200/tmb-20240630x10q.htm | 13 | false | 10-Q|table_context|6-15 | [
{
"fact_id": "ac8ad3985e0c97de71f31343c5eeedc7dea0a28d8671f7200a4cf6b12b33ce90",
"concept": "us-gaap#DebtSecuritiesTradingAndEquitySecuritiesFvNiCost",
"unit": "monetary:USD",
"period": "instant:2024-06-30",
"value": "24151932",
"displayed_text": "24,151,932",
"text_start": 113,
"tex... | [
{
"span_text": "30,",
"start": 7,
"end": 10,
"class": "date"
},
{
"span_text": "2024",
"start": 11,
"end": 15,
"class": "year"
}
] |
0117c7c8f9bf55434169c71bcbbe16fc6b5811a8f9ddcdf59f51f06a1d017f70 | 0000723188 | CBU | COMMUNITY BANK SYSTEM, INC. | 6021 | 000114036120004510 | 10-K | 2020-03-02 | 2,019 | FY | notes | New Accounting Pronouncements | conomic conditions and forecasts. The development of these models required the evaluation of data requirements, a determination of loan segments, the determination of the model construct for each loan segment and the development of a qualitative framework. In addition, the Company evaluated its CECL models’ sensitivity... | The Company adopted ASU No. 2016-13 on January 1, 2020 using a modified retrospective approach, and recorded a net cumulative-effect adjustment that increased retained earnings by $ 0.5 million. This adjustment was a result of a $ 0.7 million decrease in the allowance for loan losses and a $ 1.0 million adjustment to l... | https://www.sec.gov/Archives/edgar/data/723188/000114036120004510/form10k.htm | 4 | false | 10-K|notes|2-5 | [
{
"fact_id": "f9a3907b0e005ebb4c68763c01b921ea9408de7c0185d711c55a244f96c79bf1",
"concept": "us-gaap#CumulativeEffectOnRetainedEarningsNetOfTax1",
"unit": "monetary:USD",
"period": "duration:2019-01-01..2019-12-31",
"value": "500000",
"displayed_text": "0.5",
"text_start": 182,
"text... | [
{
"span_text": "2016",
"start": 28,
"end": 32,
"class": "year"
},
{
"span_text": "13",
"start": 33,
"end": 35,
"class": "date"
},
{
"span_text": "1,",
"start": 47,
"end": 49,
"class": "date"
},
{
"span_text": "2020",
"start": 50,
"end": 54,
... |
0050df18864c5dc121d1c30fbfcf6825e1ae98f9597997cdaf2fe7c3f3b9468b | 0001075736 | CXDO | Crexendo, Inc. | 4813 | 000165495423002860 | 10-K | 2023-03-14 | 2,022 | FY | notes | 16. Leases | tax benefits during the years ended December 31, 2022 and 2021 were as follows (in thousands): Balance as of January 1, 2021 $ - Reductions due to lapsed statute of limitations - Balance as of December 31, 2021 - Reductions due to lapsed statute of limitations - Balance as of December 31, 2022 $ - Estimated interest an... | We currently lease other assets under multiple operating leases. The leases expire on various dates through 2027 and the interest rates range from 2.81 % to 15.74 %. The expense is included in cost of product expenses and totaled approximately $ 79,000 and $ 63,000 for the years ended December 31, 2022 and 2021, respec... | https://www.sec.gov/Archives/edgar/data/0001075736/000165495423002860/cxdo_10k.htm | 13 | true | 10-K|notes|6-15 | [
{
"fact_id": "6379fc9875fae228c09a4c514f43567d37ae5d691fd13d65791cc1804bf8a9fc",
"concept": "us-gaap#DebtInstrumentInterestRateDuringPeriod",
"unit": "pure",
"period": "duration:2022-01-01..2022-12-31",
"value": "0.0281",
"displayed_text": "2.81",
"text_start": 147,
"text_end": 151,
... | [
{
"span_text": "2027",
"start": 108,
"end": 112,
"class": "year"
},
{
"span_text": "31,",
"start": 295,
"end": 298,
"class": "date"
},
{
"span_text": "2022",
"start": 299,
"end": 303,
"class": "year"
},
{
"span_text": "2021,",
"start": 308,
"en... |
005534a117f4ae0a95ef177c6363f87ca1027c2a54a48a7884bdf2c8b597ee9e | 0001561921 | TELA | TELA Bio, Inc. | 3841 | 000155837025003460 | 10-K | 2025-03-21 | 2,024 | FY | notes | 401(k) Defined Contribution Plan | 2.9 million, $ 6.0 million and $ 3.6 million at December 31, 2024, 2023 and 2022, respectively. The total unrecognized compensation expense at December 31, 2024 related to RSUs was $ 4.0 million, which is expected to be recognized in expense over a weighted-average period of approximately 2.4 years. (10) Employee Benef... | The Company sponsors a 401(k) defined-contribution plan covering all employees. Participants are permitted to contribute up to 100 % of their eligible annual pretax compensation up to an established federal limit on aggregate participant contributions. Discretionary contributions made by the Company, if any, are determ... | https://www.sec.gov/Archives/edgar/data/1561921/000155837025003460/0001558370-25-003460-index.htm | 16 | true | 10-K|notes|6-15 | [
{
"fact_id": "2b4f398d38cfc2ff3c2f9bcb50c852ed03a73bac8b690a9f16e8a56fb9ec21ad",
"concept": "us-gaap#DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
"unit": "pure",
"period": "duration:2024-01-01..2024-12-31",
"value": "1",
"displayed_text": "100",
"text_start": 127... | [
{
"span_text": "401",
"start": 23,
"end": 26,
"class": "untagged_amount"
},
{
"span_text": "23",
"start": 572,
"end": 574,
"class": "date"
},
{
"span_text": "31,",
"start": 663,
"end": 666,
"class": "untagged_amount"
},
{
"span_text": "2024,",
"sta... |
04c3e551070cb0e18cd538d1ddd475796ec84df94f32cb5913928c5c6387eee2 | 0000766421 | ALK | ALASKA AIR GROUP, INC. | 4512 | 000076642124000031 | 10-Q | 2024-05-03 | 2,024 | Q1 | table_context | null | Cash, cash equivalents, and restricted cash at end of the period $ 913 $ 537 9 | Three Months Ended March 31, |
(in millions) | 2024 | 2023 |
Supplemental disclosure: |
Cash paid during the period for: |
Interest, net of amount capitalized | $ | 35 | $ | 32 |
Non-cash transactions: |
Right-of-use assets acquired through operating leases | 13 | 111 |
Property and equipment acquired through the issua... | https://www.sec.gov/Archives/edgar/data/766421/000076642124000031/alk-20240331.htm | 12 | true | 10-Q|table_context|6-15 | [
{
"fact_id": "5efb74974382b3e0ab32844c72ac13ce61dd78d191eda185a4c2fe486bc9fc86",
"concept": "us-gaap#InterestPaidNet",
"unit": "monetary:USD",
"period": "duration:2024-01-01..2024-03-31",
"value": "35000000",
"displayed_text": "35",
"text_start": 165,
"text_end": 167,
"dimensions... | [
{
"span_text": "31,",
"start": 25,
"end": 28,
"class": "date"
},
{
"span_text": "2024",
"start": 47,
"end": 51,
"class": "year"
},
{
"span_text": "2023",
"start": 54,
"end": 58,
"class": "year"
}
] |
0049590ce05f7c2edd4399ab2d1c84ef86da826b3f3c19420589a72464d6fdd3 | 0001467858 | GM | GENERAL MOTORS COMPANY | 3711 | 000146785825000096 | 10-Q | 2025-05-01 | 2,025 | Q1 | notes | GM Financial The following table presents debt of GM Financial: | 2.0 billion facility allocated for exclusive use by GM Financial. (d) Includes coupon rates on debt denominated in various foreign currencies and interest free loans. In March 2025, we renewed our five-year , $ 10.0 billion facility, which now matures March 25, 2030. We also renewed our three-year , $ 4.1 billion facil... | March 31, 2025 | December 31, 2024 |
Carrying Amount | Fair Value | Carrying Amount | Fair Value |
Secured debt | $ | 48,886 | $ | 49,107 | $ | 49,573 | $ | 49,753 |
Unsecured debt | 68,152 | 68,425 | 64,691 | 65,258 |
Total GM Financial debt | $ | 117,037 | $ | 117,532 | $ | 114,264 | $ | 115,010 |
Fair value utilizin... | https://www.sec.gov/Archives/edgar/data/1467858/000146785825000096/gm-20250331.htm | 21 | false | 10-Q|notes|16-40 | [
{
"fact_id": "771dc2bc094820ab7fa7a631de29ee424a9578aed8723dadd3fbe7f2da869c41",
"concept": "us-gaap#LongTermDebt",
"unit": "monetary:USD",
"period": "instant:2025-03-31",
"value": "48886000000",
"displayed_text": "48,886",
"text_start": 118,
"text_end": 124,
"dimensions": [
... | [
{
"span_text": "31,",
"start": 6,
"end": 9,
"class": "date"
},
{
"span_text": "2025",
"start": 10,
"end": 14,
"class": "year"
},
{
"span_text": "31,",
"start": 26,
"end": 29,
"class": "date"
},
{
"span_text": "2024",
"start": 30,
"end": 34,
... |
004ec50a3f33b7f459b9971c9acf34f7c874a73cd13b5522d774498e6980bcca | 0000921299 | KYNB | FIBROGEN, INC. | 2834 | 000156459022008804 | 10-K/A | 2022-03-04 | 2,021 | FY | notes | Years Ended December 31, | $ 19.27 | As of December 31, 2021, there was $ 56.4 million of total unrecognized compensation costs, net of estimated forfeitures, related to non-vested stock option awards granted that will be recognized on a straight-line basis over the weighted-average period of 2.57 years. As of December 31, 2021, there was $ 52.3 million o... | https://www.sec.gov/Archives/edgar/data/0000921299/000156459022008804/fgen-10ka_20211231.htm | 2 | false | 10-K|notes|2-5 | [
{
"fact_id": "49e61b84ff8da69655aecf9dc8f7c8cf78f0e03d32a40b27493999497208ea1d",
"concept": "us-gaap#EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
"unit": "monetary:USD",
"period": "instant:2021-12-31",
"value": "56400000",
"displayed... | [
{
"span_text": "31,",
"start": 15,
"end": 18,
"class": "date"
},
{
"span_text": "2021,",
"start": 19,
"end": 24,
"class": "year"
},
{
"span_text": "2.57",
"start": 257,
"end": 261,
"class": "date"
},
{
"span_text": "31,",
"start": 284,
"end": 2... |
00497c0aecd8c704133f3a681d3c6692bdab22b2c55d2a0928a7ee7a6f8b427d | 0001784058 | PNYG | PONY GROUP INC. | 7500 | 000121390024097452 | 10-Q | 2024-11-13 | 2,024 | Q3 | notes | NOTE 4 - MAJOR SUPPLIERS AND CUSTOMERS | 503,543 Total due to related parties $ 599,677 $ 503,543 Universe Travel entered into a Lease Agreement with Shenzhen Yilutong Technology Co. Ltd (founded by Ms. Wenxian Fan in December 2015.), pursuant to which the Company rented a portion at Engineer Experiment Building, A202, 7 Gaoxin South Avenue, Nanshan District,... | The
Company purchased majority of its subcontracted services from four major suppliers: Changying Business Limited, Shenzhen Yuegang
Liantong Car Service., Ltd, Shenzhen Zhuorui Car Service., Ltd, Shenzhen Wanjin Yuegang Car Service., Ltd, and, representing 32.39 %, 21.98 %,
17.67 % and 10.53 % of the cost, respectivel... | https://www.sec.gov/Archives/edgar/data/1784058/000121390024097452/0001213900-24-097452-index.htm | 11 | false | 10-Q|notes|6-15 | [
{
"fact_id": "91c45a7a4579056dc2cc2ba906aab2b4f8f5c258011bc6734418c83164d37e06",
"concept": "us-gaap#ConcentrationRiskPercentage1",
"unit": "pure",
"period": "duration:2024-01-01..2024-09-30",
"value": "0.3239",
"displayed_text": "32.39",
"text_start": 258,
"text_end": 263,
"dime... | [
{
"span_text": "30,",
"start": 358,
"end": 361,
"class": "date"
},
{
"span_text": "2024",
"start": 362,
"end": 366,
"class": "year"
},
{
"span_text": "30,",
"start": 622,
"end": 625,
"class": "date"
},
{
"span_text": "2023",
"start": 626,
"end"... |
005850839cf48a1d36a474b3ba4b00b8141302b56e5667e79d72e214050df017 | 0001652539 | SNRG | SUSGLOBAL ENERGY CORP. | 4953 | 000106299324020888 | 10-K/A | 2024-12-19 | 2,023 | FY | notes | SusGlobal E nergy Corp. Notes to the Consolidated Financial Statements December 31, 2023 and 2022 (Expressed in United States Dollars) | olidated financial statements of SusGlobal and its wholly-owned subsidiaries, SusGlobal Energy Canada Corp. ("SGECC"), SusGlobal Energy Canada I Ltd. ("SGECIL"), SusGlobal Energy Belleville Ltd. ("SGEBL"), SusGlobal Energy Hamilton Ltd. ("SGEHL") and 1684567 Ontario Inc. ("1684567") (together, the "Company"), have been... | 2. Going Concern
The consolidated financial statements have been prepared in accordance with US GAAP, which assumes that the Company will be able to meet its obligations and continue its operations for the next twelve months.
The Company incurred a net loss of $ 8,225,334 (2022-$ 12,010,548 ) for the year ended Decembe... | https://www.sec.gov/Archives/edgar/data/1652539/000106299324020888/form10ka.htm | 10 | false | 10-K|notes|6-15 | [
{
"fact_id": "88689b70d09ba1bb7b86a109a02fa862fa5f6ddb25c940f3441f932192b29377",
"concept": "us-gaap#NetIncomeLoss",
"unit": "monetary:USD",
"period": "duration:2023-01-01..2023-12-31",
"value": "-8225334",
"displayed_text": "8,225,334",
"text_start": 263,
"text_end": 272,
"dimen... | [
{
"span_text": "2",
"start": 0,
"end": 1,
"class": "other"
},
{
"span_text": "(2022",
"start": 273,
"end": 278,
"class": "year"
},
{
"span_text": "31,",
"start": 322,
"end": 325,
"class": "date"
},
{
"span_text": "2023",
"start": 326,
"end": 33... |
004b0537640ef5b3687af170983ff40583c5700f3197ed6578b672f89f548a61 | 0001665918 | USFD | US FOODS HOLDING CORP. | 5140 | 000166591822000120 | 10-Q | 2022-05-12 | 2,022 | Q1 | notes | ABL Facility | 4,890 $ 4,916 As of April 2, 2022, approximately 47 % of the Company’s total debt bears interest at a floating rate. ABL Facility | USF’s asset based senior secured revolving credit facility (the “ABL Facility”) provides USF with loan commitments having a maximum aggregate principal amount of $ 1,990 million. The ABL Facility is scheduled to mature on May 31, 2024.
Borrowings under the ABL Facility bear interest, at USF’s periodic election, at a ra... | https://www.sec.gov/Archives/edgar/data/1665918/000166591822000120/usfd-20220402.htm | 11 | false | 10-Q|notes|6-15 | [
{
"fact_id": "52dc85eb0b87a98bbda4a9bb52d756f53de205b7307a0cbc8e5bb2edfb4fadbb",
"concept": "us-gaap#LineOfCreditFacilityMaximumBorrowingCapacity",
"unit": "monetary:USD",
"period": "instant:2022-04-02",
"value": "1990000000",
"displayed_text": "1,990",
"text_start": 164,
"text_end":... | [
{
"span_text": "31,",
"start": 226,
"end": 229,
"class": "date"
},
{
"span_text": "2024",
"start": 230,
"end": 234,
"class": "year"
},
{
"span_text": "2,",
"start": 639,
"end": 641,
"class": "date"
},
{
"span_text": "2022",
"start": 642,
"end":... |
005ce9317145fd633990d5b22f0c5e58588edd497d3e80bce8c7074d974df499 | 0001601830 | RXRX | RECURSION PHARMACEUTICALS, INC. | 2836 | 000160183023000069 | 10-Q | 2023-11-09 | 2,023 | Q3 | notes | Class A and B Common Shares Authorization | the agreement have been publicly sold by the holders or all shares cease to be registrable securities. In the event the holders cannot sell their shares due to certain circumstances causing the agreement to be ineffective, the Company must pay each holder of shares outstanding on the date and each month thereafter 1.0... | In April 2021 , the Company’s Board of Directors authorized two classes of common stock, Class A and Class B. The rights of the holders of Class A and B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share. Each share of Class B c... | https://www.sec.gov/Archives/edgar/data/1601830/000160183023000069/rxrx-20230930.htm | 6 | true | 10-Q|notes|2-5 | [
{
"fact_id": "c4b40bb6842dd2b84ea068bc1b6f1a3dfc45dec8d0704e23dd641fb17dcc1702",
"concept": "ext-0001601830#NumberOfClassesOfCommonStockAuthorized",
"unit": "other",
"period": "instant:2021-04-30",
"value": "2",
"displayed_text": "two",
"text_start": 60,
"text_end": 63,
"dimensio... | [
{
"span_text": "2021",
"start": 9,
"end": 13,
"class": "year"
},
{
"span_text": "30,",
"start": 580,
"end": 583,
"class": "date"
},
{
"span_text": "2023,",
"start": 584,
"end": 589,
"class": "year"
},
{
"span_text": "30,",
"start": 1017,
"end":... |
004e83370ae0fe28458101c031b99ac8889bc11b16af5a1c67d08f833b2595fc | 0000944745 | CIVB | Civista Bancshares, Inc. | 6022 | 000095017023008123 | 10-K | 2023-03-15 | 2,022 | FY | notes | NOTE 1 - SUMMARY OF SIG NIFICANT ACCOUNTING POLICIES | See accompanying notes to consolidated financial statements 69 CIVISTA BANCSHARES, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS December 31, 2022, 2021 and 2020 (Amounts in thousands, except share data) | NOTE 1 - SUMMARY OF SIG NIFICANT ACCOUNTING POLICIES
The following is a summary of the accounting policies adopted by Civista Bancshares, Inc., which have a significant effect on the Consolidated Financial Statements.
Nature of Operations and Principles of Consolidation : The Consolidated Financial Statements include t... | https://www.sec.gov/Archives/edgar/data/944745/000095017023008123/civb-20221231.htm | 9 | true | 10-K|notes|6-15 | [
{
"fact_id": "375373332c24fb5f58f02ceb566a9944f61fed65b7fe583b83b2965d4222d0c9",
"concept": "ext-0000944745#PercentageOfInsuranceCommissionRevenueOfRevenue",
"unit": "pure",
"period": "duration:2022-01-01..2022-12-31",
"value": "0.01",
"displayed_text": "1.0",
"text_start": 2331,
"te... | [
{
"span_text": "1",
"start": 5,
"end": 6,
"class": "note_ref"
},
{
"span_text": "2022",
"start": 1980,
"end": 1984,
"class": "year"
},
{
"span_text": "31,",
"start": 2391,
"end": 2394,
"class": "date"
},
{
"span_text": "2022,",
"start": 2395,
"... |
007e0b2e158fd8940cdea158ea413837621678baf41d05dd465e85f19ef205c6 | 0001815974 | ANEB | ANEBULO PHARMACEUTICALS, INC. | 2834 | 000149315223041171 | 10-Q | 2023-11-14 | 2,024 | Q1 | table_context | (unaudited) | 11,670,151 The accompanying notes are an integral part of these condensed financial statements. 1 Anebulo Pharmaceuticals, Inc. Condensed Statements of Operations (unaudited) | Three Months Ended September 30, |
2023 |
2022 |
Research and development |
$ | 1,270,220 |
$ | 1,223,776 |
General and administrative |
| 1,273,458 |
| 1,388,271 |
Total operating expenses |
| 2,543,678 |
| 2,612,047 |
Loss from operations |
| ( 2,543,678 | ) |
| ( 2,612,047 | ) |
Other (income) expenses: |
Interest i... | https://www.sec.gov/Archives/edgar/data/1815974/000149315223041171/0001493152-23-041171-index.htm | 23 | true | 10-Q|table_context|16-40 | [
{
"fact_id": "a424173f80438e4f97eafb9c99cb2f519bf343ad9711614337ad76578f57f50e",
"concept": "us-gaap#ResearchAndDevelopmentExpense",
"unit": "monetary:USD",
"period": "duration:2023-07-01..2023-09-30",
"value": "1270220",
"displayed_text": "1,270,220",
"text_start": 80,
"text_end": 8... | [
{
"span_text": "30,",
"start": 29,
"end": 32,
"class": "date"
},
{
"span_text": "2023",
"start": 35,
"end": 39,
"class": "year"
},
{
"span_text": "2022",
"start": 42,
"end": 46,
"class": "year"
}
] |
0071d4301a60ef9f238596a749686da8c8348df2179f141b135d113a16f271bc | 0001845257 | LFST | LifeStance Health Group, Inc. | 8000 | 000119312526211814 | 10-Q | 2026-05-07 | 2,026 | Q1 | table_context | null | $ 0.00 The Company has issued potentially dilutive instruments in the form of RSAs, RSUs and stock options. The following potentially dilutive shares are excluded from the computation of dil uted earnings per share for the periods presented because including them would have been anti-dilutive: | As of March 31,
2026
2025
RSAs, RSUs and stock options
7,570
35,156 | https://www.sec.gov/Archives/edgar/data/0001845257/000119312526211814/lfst-20260331.htm | 2 | true | 10-Q|table_context|2-5 | [
{
"fact_id": "695b52604ac93ee28577aeb4e019e6ef3fcd0b0fceeb720c5cc4e34c301b9ccf",
"concept": "us-gaap#AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"unit": "shares",
"period": "duration:2026-01-01..2026-03-31",
"value": "7570000",
"displayed_text": "7,570",
"text... | [
{
"span_text": "31,",
"start": 12,
"end": 15,
"class": "date"
},
{
"span_text": "2026",
"start": 16,
"end": 20,
"class": "year"
},
{
"span_text": "2025",
"start": 21,
"end": 25,
"class": "year"
}
] |
018f44ad71cc47c38a4c34827430f2e5c720193c7423cd0dc18337af5d87baa2 | 0001816319 | LYTHF | LYTUS TECHNOLOGIES HOLDINGS PTV. LTD. | 7374 | 000121390022059516 | 20-F | 2022-09-28 | 2,022 | FY | table_context | null | — 125,458 74,620,143 73,460,646 | Cable
business |
Telemedicine
Services |
Total |
For
the year ended March 31, 2022 |
For
the year ended March 31, 2021 |
For
the year ended March 31, 2022 |
For
the year ended March 31, 2021 |
For
the year ended March 31, 2022 |
For
the year ended March 31, 2021 |
Capital expenditure on: |
Tangible assets |
| — |
| 1,2... | https://www.sec.gov/Archives/edgar/data/1816319/000121390022059516/0001213900-22-059516-index.htm | 14 | false | 20-F|table_context|6-15 | [
{
"fact_id": "8d840a4a979982240bbdd3a84ffaef79773eb127a8a433633f78981fbc00b205",
"concept": "ext-0001816319#TangibleAssets",
"unit": "monetary:USD",
"period": "instant:2021-03-31",
"value": "1205396",
"displayed_text": "1,205,396",
"text_start": 317,
"text_end": 326,
"dimensions"... | [
{
"span_text": "31,",
"start": 74,
"end": 77,
"class": "date"
},
{
"span_text": "2022",
"start": 78,
"end": 82,
"class": "year"
},
{
"span_text": "31,",
"start": 110,
"end": 113,
"class": "date"
},
{
"span_text": "2021",
"start": 114,
"end": 11... |
006624f33ded10d7559132572f30e123eb6fcfacf9641c9e73e47d5e7fe0dba1 | 0001591588 | GOLD | A-Mark Precious Metals, Inc. | 5094 | 000095017024124015 | 10-Q | 2024-11-08 | 2,025 | Q1 | notes | (Unaudited) | the fair value of an indefinite-lived intangible asset is less than its carrying value, an impairment loss will be recognized for the amount by which the carrying amount exceeds the indefinite-lived intangible asset’s fair value. The methods used to estimate the fair value measurements of the Company’s reporting units ... | Long-Term Investments
Investments in privately-held entities are accounted for using the equity method when the Company has significant influence, but not control, over the investee. Significant influence is generally deemed to exist if the Company’s ownership interest in the voting stock of the investee ranges between... | https://www.sec.gov/Archives/edgar/data/1591588/000095017024124015/0000950170-24-124015-index.htm | 2 | false | 10-Q|notes|2-5 | [
{
"fact_id": "92c82a1fbfefb649acc02ecb991a8c133e7120720951d932883d8a7b57889ac9",
"concept": "ext-0001591588#EquityMethodInvestmentOwnershipThresholdPercentage",
"unit": "pure",
"period": "instant:2024-09-30",
"value": "0.2",
"displayed_text": "20",
"text_start": 321,
"text_end": 323,... | [
{
"span_text": "30,",
"start": 2528,
"end": 2531,
"class": "date"
},
{
"span_text": "2024",
"start": 2532,
"end": 2536,
"class": "year"
},
{
"span_text": "30,",
"start": 2546,
"end": 2549,
"class": "date"
},
{
"span_text": "2024",
"start": 2550,
... |
0085a6b3d1d5d70264d012bfa76006db920fb4c2864e27cf114f08ab9b32ca92 | 0001751707 | OZVN | United Express Inc. | 4700 | 000160706223000231 | 10-Q | 2023-04-25 | 2,023 | Q3 | table_context | BALANCE SHEET | Item 5. Other Information 14 Item 6. Exhibits, Signatures 15 2 UNITED EXPRESS, INC. BALANCE SHEET MARCH 31, 2023 AND JUNE 30, 2022 | March
31, 2023 |
June
30, 2022 |
Unaudited |
Audited |
ASSETS |
CURRENT
ASSETS: |
Cash |
$ |
2,406 |
$ |
7,737 |
TOTAL
CURRENT ASSETS |
$ |
2,406 |
$ |
7,737 |
TOTAL
ASSETS |
$ |
2,406 |
$ |
7,737 |
LIABILITIES
AND STOCKHOLDERS’ EQUITY |
CURRENT
LIABILITIES |
Accrued
Accounts Payable |
1 |
1 |
Accrued
Taxes |
0 |
0 |
T... | https://www.sec.gov/Archives/edgar/data/1751707/000160706223000231/0001607062-23-000231-index.htm | 26 | false | 10-Q|table_context|16-40 | [
{
"fact_id": "0d8529e362e878fd8a4a106b183b6adb3f05114e205eed8621ceafe062ad520b",
"concept": "us-gaap#Cash",
"unit": "monetary:USD",
"period": "instant:2023-03-31",
"value": "2406",
"displayed_text": "2,406",
"text_start": 93,
"text_end": 98,
"dimensions": [],
"scale": 0,
... | [
{
"span_text": "31,",
"start": 6,
"end": 9,
"class": "date"
},
{
"span_text": "2023",
"start": 10,
"end": 14,
"class": "year"
},
{
"span_text": "30,",
"start": 22,
"end": 25,
"class": "date"
},
{
"span_text": "2022",
"start": 26,
"end": 30,
... |
16700fb76d736636b4a27c629e3b62632afe42fc4a8fc0a0da97baf9004933e4 | 0001690511 | GOOS | CANADA GOOSE HOLDINGS INC. | 2300 | 000169051126000012 | 20-F | 2026-05-15 | 2,026 | FY | table_context | null | il 2, 2028. F-54 Notes to the Consolidated Financial Statements March 29, 2026 (in millions of Canadian dollars, except share and per share data) Note 22. Financial risk management objectives and policies The Company’s primary risk management objective is to protect the Company’s assets and cash flow, in order to incre... | 2027 | 2028 | 2029 | 2030 | 2031 | Thereafter | Total |
$ | $ | $ | $ | $ | $ | $ |
Accounts payable and accrued liabilities | 214.0 | — | — | — | — | — | 214.0 |
Term Loan
| 4.2 | 4.2 | 4.2 | 4.2 | 4.2 | 395.8 | 416.8 |
Interest commitments relating to borrowings 1
| 29.9 | 29.9 | 29.9 | 29.9 | 29.9 | 41.7 | 191.2 |
L... | https://www.sec.gov/Archives/edgar/data/0001690511/000169051126000012/goos-20260329.htm | 49 | true | 20-F|table_context|41+ | [
{
"fact_id": "24f3ea743c00dc37eb415f93fa2c719e636d42090625e1348598f74b24bf1505",
"concept": "ifrs#TradeAndOtherPayablesUndiscountedCashFlows",
"unit": "monetary:CAD",
"period": "instant:2026-03-29",
"value": "214000000",
"displayed_text": "214.0",
"text_start": 127,
"text_end": 132,
... | [
{
"span_text": "2027",
"start": 0,
"end": 4,
"class": "year"
},
{
"span_text": "2028",
"start": 7,
"end": 11,
"class": "year"
},
{
"span_text": "2029",
"start": 14,
"end": 18,
"class": "year"
},
{
"span_text": "2030",
"start": 21,
"end": 25,
... |
005d0e46049488657cdca77d0e3d7bfa0529cf9439b5ffea3ef20b48edf3d2cd | 0001308106 | SEAL-PA | SEAPEAK LLC | 4400 | 000162828022008232 | 20-F | 2022-04-04 | 2,021 | FY | notes | NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS | inimum speed and performance metrics are not met. In addition, certain time-charter contracts contain provisions allowing the Company to be compensated for increases in the Company's costs during the term of the charter. Such provisions may be in the form of annual hire rate adjustments for changes in inflation indices... | (all tabular amounts stated in thousands of U.S. Dollars, except unit and per unit data and foreign currency exchange rates or unless otherwise indicated)
Company may earn a profit share consideration, which occurs when actual spot tanker rates earned by the vessel exceed certain thresholds for a period of time. The Co... | https://www.sec.gov/Archives/edgar/data/1308106/000162828022008232/tk-20211231.htm | 4 | true | 20-F|notes|2-5 | [
{
"fact_id": "05d80aa899898403245220e0f50cdda2eeab7d7ab18e9d62c817099ae102423e",
"concept": "us-gaap#ContractWithCustomerLiability",
"unit": "monetary:USD",
"period": "instant:2021-12-31",
"value": "22200000",
"displayed_text": "22.2",
"text_start": 1117,
"text_end": 1121,
"dimen... | [
{
"span_text": "31,",
"start": 414,
"end": 417,
"class": "date"
},
{
"span_text": "2021,",
"start": 418,
"end": 423,
"class": "year"
},
{
"span_text": "2022",
"start": 600,
"end": 604,
"class": "year"
},
{
"span_text": "2039",
"start": 609,
"en... |
0f90591e652c54d77fa7e9d6670d2fa757be6b32d573b03d1ae6fe360864f308 | 0001778982 | HUIZ | Huize Holding Limited | 6411 | 000119312522121891 | 20-F | 2022-04-27 | 2,021 | FY | table_context | null | esses. Total cash consideration transferred for the acquisitions amounted to RMB 2,712 thousand. The purchase price allocated to the fair value of assets acquired and liabilities assumed were RMB 3,452 thousand and RMB 740 thousand, respectively. No goodwill was recognized in this acquisition. F-3 9 Table of Contents H... | As of |
December 31, 2020 |
December 31, 2021 |
RMB |
RMB |
Balance at the beginning of the year
1,127 |
1,724 |
Provision for doubtful accounts
709 |
1,445 |
Write-offs
( 112 |
) |
— |
Balance at the end of the year
1,724 |
3,169 | | https://www.sec.gov/Archives/edgar/data/0001778982/000119312522121891/d272448d20f.htm | 8 | true | 20-F|table_context|6-15 | [
{
"fact_id": "63012b0eef8a2be4d0ae43da378eb1074afc889a18731753fbd6b144d55393f7",
"concept": "us-gaap#AllowanceForDoubtfulAccountsReceivableCurrent",
"unit": "monetary:CNY",
"period": "instant:2019-12-31",
"value": "1127000",
"displayed_text": "1,127",
"text_start": 97,
"text_end": 10... | [
{
"span_text": "31,",
"start": 17,
"end": 20,
"class": "date"
},
{
"span_text": "2020",
"start": 21,
"end": 25,
"class": "year"
},
{
"span_text": "31,",
"start": 37,
"end": 40,
"class": "date"
},
{
"span_text": "2021",
"start": 41,
"end": 45,
... |
01093c1960c0d98b5f9b75fd11b471d9debf9dfa2af56efb8e86f9719a38abfc | 0000928876 | TSEM | TOWER SEMICONDUCTOR LTD. | 3674 | 000117891324001397 | 20-F | 2024-04-22 | 2,023 | FY | table_context | TPSCo (continued) | IES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2023 (dollars in thousands, except per share data) NOTE 14: COMMITMENTS AND CONTINGENCIES (continued) B. TPSCo (continued) The remaining machinery and equipment were sold to third parties. The restructuring process, including the transfer and installatio... | Details
Asset disposal accrual
Other Restructuring costs accrual
Accrued balance as of January 1, 2022
$
2,250
$
-
Expenses accrued
-
10,684
Accruals related to assets
521
2,654
Cash payments
( 808
)
( 5,703
)
Accrued balance as of December 31, 2022
$
1,963
$
7,635
Expenses accrued
-
19,662
Accruals related to assets
(... | https://www.sec.gov/Archives/edgar/data/0000928876/000117891324001397/zk2431315.htm | 18 | true | 20-F|table_context|16-40 | [
{
"fact_id": "71873e7d52843a60a1ccb2fe9a7056f269e3c7e55e42a8880a47ca52766e485e",
"concept": "ext-0000928876#FactoryCessationRelatedAccruals",
"unit": "monetary:USD",
"period": "instant:2021-12-31",
"value": "2250000",
"displayed_text": "2,250",
"text_start": 105,
"text_end": 110,
... | [
{
"span_text": "1,",
"start": 95,
"end": 97,
"class": "date"
},
{
"span_text": "2022",
"start": 98,
"end": 102,
"class": "year"
},
{
"span_text": "31,",
"start": 241,
"end": 244,
"class": "date"
},
{
"span_text": "2022",
"start": 245,
"end": 24... |
02c53d8645df911146eeeb16033f8fde633e06af0b4a392ad4d1a148b2a88bf0 | 0001775734 | BENF | Beneficient | 6199 | 000177573423000008 | 10-K | 2023-07-13 | 2,023 | FY | notes | 14. Net Loss per Unit | ibed in Note 10. During the year ended March 31, 2023, BFF purchased $ 0.1 million of the member interest back from the controlling interest holder. As a Class A member of CT Risk Management, the holder is entitled to distributions first on a pro rata basis with other Class A members until the initial capital contribut... | Basic and diluted net loss attributable to The Beneficient Company Group L.P. per common unit for the year ended March 31, 2023, the three months ended March 31, 2022 , and the years ended December 31, 2021 and 2020, are as follows:
(Dollars in thousands) | Year Ended March 31, | Three Months Ended March 31, | Year End... | https://www.sec.gov/Archives/edgar/data/1775734/000177573423000008/ben-20230331.htm | 72 | true | 10-K|notes|41+ | [
{
"fact_id": "6329e59f6e58e0fe6d4c0d7706f98482403ca3a02f8c5ab4917a107d43fc8c68",
"concept": "us-gaap#ProfitLoss",
"unit": "monetary:USD",
"period": "duration:2022-04-01..2023-03-31",
"value": "-252100000",
"displayed_text": "252,100",
"text_start": 385,
"text_end": 392,
"dimensio... | [
{
"span_text": "31,",
"start": 119,
"end": 122,
"class": "date"
},
{
"span_text": "2023,",
"start": 123,
"end": 128,
"class": "year"
},
{
"span_text": "31,",
"start": 158,
"end": 161,
"class": "date"
},
{
"span_text": "2022",
"start": 162,
"end... |
004e86e4058ae3640e3cdfe44ad542f098228a64de126550cc8668145339fd0c | 0001227282 | SPOWF | STRATA POWER CORPORATION | 1311 | 000168316822002181 | 20-F | 2022-03-31 | 2,021 | FY | notes | Fair Value of Financial Instruments | e used to repurchase common stock at market value. The number of shares remaining after the proceeds are exhausted represents the potentially dilutive effect of the securities. For the years ended December 31, 2021 and 2020, all of the outstanding options and warrants had an exercise price above the average stock price... | The book values of GST receivables, notes receivable,
accounts payable and accrued expenses approximate their respective fair values due to the short-term nature of these instruments. The
fair value hierarchy under GAAP distinguishes between assumptions based on market data (observable inputs) and an entity’s own assum... | https://www.sec.gov/Archives/edgar/data/1227282/000168316822002181/0001683168-22-002181-index.htm | 8 | false | 20-F|notes|6-15 | [
{
"fact_id": "72d670f6af4d3397189a717c6d4f55e698aa9454f111f7a10faa04d5a96c404a",
"concept": "us-gaap#DerivativeFairValueOfDerivativeLiability",
"unit": "monetary:USD",
"period": "instant:2021-12-31",
"value": "210929",
"displayed_text": "210,929",
"text_start": 1212,
"text_end": 1219... | [
{
"span_text": "11",
"start": 791,
"end": 793,
"class": "other"
},
{
"span_text": "31,",
"start": 1100,
"end": 1103,
"class": "date"
},
{
"span_text": "2021",
"start": 1104,
"end": 1108,
"class": "year"
},
{
"span_text": "31,",
"start": 1120,
"... |
0051d0184796920fa1be6c33ad09b534ff9e1a5b324ebd7eeb3e8eff29d19dd4 | 0001606757 | KE | KIMBALL ELECTRONICS, INC. | 3672 | 000160675724000014 | 10-Q | 2024-05-08 | 2,024 | Q3 | notes | Note 13. Share Owners’ Equity | The estimated useful life of internal-use software ranges from 3 years to 10 years. The amortization period for the customer relationships, technology, and trade name intangible assets was 15 years, 5 years, and 10 years, respectively. We ceased amortization on the intangible assets upon meeting the held for sale class... | The Company has a Board-authorized stock repurchase plan (the “Repurchase Plan”) allowing the repurchase of up to $ 100 million of our common stock. Purchases may be made under various programs, including in open-market transactions, block transactions on or off an exchange, or in privately negotiated transactions, all... | https://www.sec.gov/Archives/edgar/data/1606757/000160675724000014/0001606757-24-000014-index.htm | 5 | true | 10-Q|notes|2-5 | [
{
"fact_id": "71c07d4d07b2ec9928f72eeae596bbd0f6a1d9d1f876d37b3539274dfeb4c59c",
"concept": "us-gaap#StockRepurchaseProgramAuthorizedAmount1",
"unit": "monetary:USD",
"period": "instant:2024-03-31",
"value": "100000000",
"displayed_text": "100",
"text_start": 116,
"text_end": 119,
... | [
{
"span_text": "31,",
"start": 517,
"end": 520,
"class": "date"
},
{
"span_text": "2024",
"start": 521,
"end": 525,
"class": "year"
},
{
"span_text": "2023,",
"start": 530,
"end": 535,
"class": "year"
}
] |
005ea1ef6d74941879cda15785ae2f6ae037cd07c511b1f852d485027cb90632 | 0001691303 | HCC | Warrior Met Coal, Inc. | 1220 | 000169130322000016 | 10-Q | 2022-05-05 | 2,022 | Q1 | notes | Note 11— Derivative Instruments | 0.06 per share, totaling approximately $ 3.1 million, which will be paid on May 13, 2022, to stockholders of record as of the close of business on May 6, 2022. May 2022 Special Dividend On May 3, 2022, the Board declared a special quarterly cash dividend of $ 0.50 per share, to be paid on May 20, 2022, to stockholders ... | The Company enters into natural gas swap contracts from time to time to hedge the exposure to variability in expected
future cash flows associated with the fluctuations in the price of natural gas related to the Company’s forecasted sales. As of March 31, 2022, the Company had natural gas swap contracts outstanding wit... | https://www.sec.gov/Archives/edgar/data/1691303/000169130322000016/0001691303-22-000016-index.htm | 7 | true | 10-Q|notes|6-15 | [
{
"fact_id": "ffc4947bccd04c8fb3278796e95c09388ce63f7f356066c0550bb2eb5f306450",
"concept": "us-gaap#DerivativeNonmonetaryNotionalAmountEnergyMeasure",
"unit": "other",
"period": "duration:2022-01-01..2022-03-31",
"value": "5900000",
"displayed_text": "5,900,000",
"text_start": 348,
... | [
{
"span_text": "31,",
"start": 252,
"end": 255,
"class": "date"
},
{
"span_text": "2022,",
"start": 256,
"end": 261,
"class": "year"
},
{
"span_text": "2023",
"start": 428,
"end": 432,
"class": "year"
},
{
"span_text": "31,",
"start": 449,
"end... |
00b9f9b8a7f06e3de9319d777b6fdddc6e32cd6401fe5828a4955dbae454a266 | 0001786352 | BILL | BILL HOLDINGS, INC. | 7372 | 000178635224000010 | 10-Q | 2024-02-09 | 2,024 | Q2 | notes | NOTE 3 – FAIR VALUE MEASUREMENT | — $ ( 12,035 ) $ ( 12,035 ) (1) The Company used the probability-weighted discounted cash flow method to estimate the contingent consideration. The significant inputs used in the fair value measurement of the contingent consideration are the probability of payout and discount rate. As these inputs are not based on obse... | There were no transfers of financial instruments between Level 1, Level 2, and Level 3 during the periods presented.
The fair values of the Company’s Level 1 instruments were derived from quoted market prices and active markets for these specific instruments.
The valuation techniques used to measure the fair values of ... | https://www.sec.gov/Archives/edgar/data/1786352/000178635224000010/0001786352-24-000010-index.htm | 6 | false | 10-Q|notes|6-15 | [
{
"fact_id": "5520a8ecd6bc4a3c0834f268a0a913e0e43d588705aa96747312cca4a8aecbb0",
"concept": "us-gaap#DebtInstrumentFaceAmount",
"unit": "monetary:USD",
"period": "instant:2023-12-31",
"value": "575000000",
"displayed_text": "575.0",
"text_start": 529,
"text_end": 534,
"dimensions... | [
{
"span_text": "1,",
"start": 63,
"end": 65,
"class": "note_ref"
},
{
"span_text": "2,",
"start": 72,
"end": 74,
"class": "note_ref"
},
{
"span_text": "3",
"start": 85,
"end": 86,
"class": "note_ref"
},
{
"span_text": "1",
"start": 156,
"end": ... |
00dc778242b558c7871bc0c44bee73ad1fa8ddb775acf1fb459da7c4a28130cd | 0001619312 | LTSV | LIGHTSTONE VALUE PLUS REIT IV, INC. | 6798 | 000118518526001826 | 10-Q | 2026-05-13 | 2,026 | Q1 | notes | Subordinated Advances – Related Party | es a disposition commission. During the second quarter of 2024, the Advisor agreed to allow the Company to temporarily defer the payment of asset management fees. As of March 31, 2026 and December 31, 2025, the Company owed the Advisor and its affiliated entities $ 2.0 million and $ 1.7 million, respectively, which is ... | On March 18, 2016, the Company and the Sponsor
entered into a subordinated unsecured loan agreement (the “Subordinated Loan Agreement”) pursuant to which the Sponsor made
aggregate principal advances of $ 12.6 million through March 31, 2017 (the termination date of the Offering). The outstanding
principal advances bear... | https://www.sec.gov/Archives/edgar/data/1619312/000118518526001826/0001185185-26-001826-index.htm | 7 | true | 10-Q|notes|6-15 | [
{
"fact_id": "d6a4cd5e5057c3b3f83d3719d3f38688fabbe48c3c160edc98738692695c6593",
"concept": "us-gaap#DebtInstrumentFaceAmount",
"unit": "monetary:USD",
"period": "instant:2016-03-18",
"value": "12600000",
"displayed_text": "12.6",
"text_start": 205,
"text_end": 209,
"dimensions":... | [
{
"span_text": "18,",
"start": 9,
"end": 12,
"class": "date"
},
{
"span_text": "2016,",
"start": 13,
"end": 18,
"class": "year"
},
{
"span_text": "31,",
"start": 232,
"end": 235,
"class": "date"
},
{
"span_text": "2017",
"start": 236,
"end": 24... |
00c85c06844171470050ae031b99f85f54d1678d2ca273c9d5e6a1f286c4bb99 | 0001136893 | FIS | Fidelity National Information Services, Inc. | 7389 | 000113689324000015 | 10-K | 2024-02-26 | 2,023 | FY | notes | Settlement Assets | cash flows from operating and investing activities for discontinued operations (in millions). December 31, 2023 2022 2021 Cash provided by (used in) operating activities - discontinued operations $ 2,257 $ 2,317 $ 2,539 Cash provided by (used in) investing activities - discontinued operations (1) $ ( 342 ) $ ( 147 ) $ ... | The principal components of the Company's settlement assets of the disposal group are as follows (in millions):
December 31, 2023 | December 31, 2022 |
Settlement assets |
Settlement deposits | $ | 56 | $ | 55 |
Merchant float | 2,594 | 2,625 |
Settlement receivables | 4,077 | 2,584 |
Total Settlement assets | $ | 6,72... | https://www.sec.gov/Archives/edgar/data/1136893/000113689324000015/0001136893-24-000015-index.htm | 8 | true | 10-K|notes|6-15 | [
{
"fact_id": "97ead4d8e38a4b476f863a59fe12288ebfe67dc4062908b2f8404b312b766aee",
"concept": "ext-0001136893#DisposalGroupIncludingDiscontinuedOperationSettlementDeposits",
"unit": "monetary:USD",
"period": "instant:2023-12-31",
"value": "56000000",
"displayed_text": "56",
"text_start": 1... | [
{
"span_text": "31,",
"start": 121,
"end": 124,
"class": "date"
},
{
"span_text": "2023",
"start": 125,
"end": 129,
"class": "year"
},
{
"span_text": "31,",
"start": 141,
"end": 144,
"class": "date"
},
{
"span_text": "2022",
"start": 145,
"end"... |
0a0e96ffd321822ec4988a89b700ed40d973124de27cf2f774ca56e7213a0716 | 0001836754 | LGCY | LEGACY EDUCATION INC. | 8200 | 000149315226023050 | 10-Q | 2026-05-14 | 2,026 | Q3 | table_context | Note 7 – Prepaid Expenses | help bridge the financial gap, all in accordance with applicable federal Truth-In-Lending regulations. Through this program, we offer payment plans to all students, regardless of financial need, for up to 7 years. The long-term portion of student receivables utilizing the TuitionFlex program was $ 2,111,840 and $ 1,966... | March 31, 2026 |
June 30, 2025 |
Books |
$ | 339,204 |
$ | 190,928 |
Supplies and other prepaid expenses |
| 2,134,638 |
| 1,192,477 |
Total prepaid expenses |
$ | 2,473,842 |
$ | 1,383,405 | | https://www.sec.gov/Archives/edgar/data/0001836754/000149315226023050/form10-q.htm | 6 | false | 10-Q|table_context|6-15 | [
{
"fact_id": "b4e6d02843285bc8c822740704d4db4971e65e369ca5918fa04c4cd3a5915b29",
"concept": "ext-0001836754#PrepaidBooks",
"unit": "monetary:USD",
"period": "instant:2026-03-31",
"value": "339204",
"displayed_text": "339,204",
"text_start": 45,
"text_end": 52,
"dimensions": [],
... | [
{
"span_text": "31,",
"start": 6,
"end": 9,
"class": "date"
},
{
"span_text": "2026",
"start": 10,
"end": 14,
"class": "year"
},
{
"span_text": "30,",
"start": 22,
"end": 25,
"class": "date"
},
{
"span_text": "2025",
"start": 26,
"end": 30,
... |
0078982df2e9adeefdb93872a4df7550ea0f9afb454fc70a17f9768b4dc15cb7 | 0001868419 | CYCU | Western Acquisition Ventures Corp. | 7371 | 000141057823001357 | 10-Q | 2023-05-22 | 2,023 | Q1 | notes | Forward Purchase Agreement | or exchange or exercise price of currently outstanding or future issuances of any securities convertible or exchangeable or exercisable for shares (other than any incentive equity outstanding immediately following the closing of the Business Combination, with such exclusion applicable only to the extent the terms and r... | The Company accounts for its Forward Purchase Agreement in accordance with the guidance contained in ASC 815-40, under which the FPA does not meet the criteria for equity treatment and must be recorded as a liability. Accordingly, the Company classifies the FPA as a liability at its fair value and adjusts the FPA to fa... | https://www.sec.gov/Archives/edgar/data/1868419/000141057823001357/0001410578-23-001357-index.htm | 25 | true | 10-Q|notes|16-40 | [
{
"fact_id": "e024363efe38eea67b0b1e973f0ca2759a8dcf0f7db1456f4a6b666917db4531",
"concept": "us-gaap#DerivativeLiabilitiesCurrent",
"unit": "monetary:USD",
"period": "instant:2023-01-10",
"value": "430021",
"displayed_text": "430,021",
"text_start": 711,
"text_end": 718,
"dimensi... | [
{
"span_text": "815",
"start": 105,
"end": 108,
"class": "note_ref"
},
{
"span_text": "40,",
"start": 109,
"end": 112,
"class": "note_ref"
},
{
"span_text": "10,",
"start": 695,
"end": 698,
"class": "date"
},
{
"span_text": "2023,",
"start": 699,
... |
089c22cf311a801aca53ca07649e708f1c11ee8715e9df9cf08cb4bf38ee1ff2 | 0001437107 | WBD | Warner Bros. Discovery, Inc. | 4841 | 000143710722000031 | 10-K | 2022-02-24 | 2,021 | FY | table_context | null | 10,671 $ 11,144 Distribution and advertising revenues are attributed to each country based on viewer location. Other revenues are attributed to each country based on customer location. Property and Equipment by Geography | |
| December 31, |
| 2021 | 2020 |
U.S. | $ | 834 | $ | 645 |
Poland | 176 | 180 |
U.K. | 164 | 149 |
Other non-U.S. | 162 | 232 |
Total property and equipment, net | $ | 1,336 | $ | 1,206 | | https://www.sec.gov/Archives/edgar/data/1437107/000143710722000031/0001437107-22-000031-index.htm | 10 | false | 10-K|table_context|6-15 | [
{
"fact_id": "f6e9ad5d3bef31fa7087890889dfa70d4512e3878442142162a4ffa64d48155b",
"concept": "us-gaap#PropertyPlantAndEquipmentNet",
"unit": "monetary:USD",
"period": "instant:2021-12-31",
"value": "834000000",
"displayed_text": "834",
"text_start": 46,
"text_end": 49,
"dimensions... | [
{
"span_text": "31,",
"start": 13,
"end": 16,
"class": "date"
},
{
"span_text": "2021",
"start": 21,
"end": 25,
"class": "year"
},
{
"span_text": "2020",
"start": 28,
"end": 32,
"class": "year"
}
] |
007ab8417d49ae738caff6ccd8d3969c7424a0f382b35ddfac1483080c9380d1 | 0001123799 | WIT | WIPRO LIMITED | 7371 | 000095017023023911 | 20-F | 2023-05-24 | 2,023 | FY | notes | Fair value | For the financial assets and liabilities subject to offsetting or similar arrangements, each agreement between the Company and the counterparty allows for net settlement of the relevant financial assets and liabilities when both elect to settle on a net basis. In the absence of such an election, financial assets and li... | Financial assets and liabilities include cash and cash equivalents, trade receivables, unbilled receivables, finance lease receivables, employee and other advances, eligible current and non-current assets, loans, borrowings and bank overdrafts, trade payables and accrued expenses, and eligible current liabilities and n... | https://www.sec.gov/Archives/edgar/data/0001123799/000095017023023911/wit-20230331.htm | 2 | false | 20-F|notes|2-5 | [
{
"fact_id": "478a05da20ab3ac45bd61713464cbeb8e9da09d851e2bc1190f9f5a36f90b3e3",
"concept": "ifrs#BorrowingsInterestRate",
"unit": "pure",
"period": "instant:2023-03-31",
"value": "0.015",
"displayed_text": "1.50",
"text_start": 1060,
"text_end": 1064,
"dimensions": [
{
... | [
{
"span_text": "31,",
"start": 880,
"end": 883,
"class": "date"
},
{
"span_text": "2022",
"start": 884,
"end": 888,
"class": "year"
},
{
"span_text": "2023,",
"start": 893,
"end": 898,
"class": "year"
},
{
"span_text": "2026",
"start": 1016,
"e... |
0116651299254bbd7c759a6baf1d5edfe0f74fd0b8c119d5e3fbaea04329c9b0 | 0001040971 | SLG | SL GREEN REALTY CORP | 6798 | 000104097123000009 | 10-K | 2023-02-17 | 2,022 | FY | notes | 19. Benefit Plans | 3,276 2027 3,325 Thereafter 200,169 Total minimum lease payments $ 216,311 Amount representing interest ( 111,988 ) Investment in sales-type leases (1) $ 104,323 (1) This amount is included in Other assets in our consolidated balance sheets. The components of lease income from sales-type leases during the years ended D... | The building employees are covered by multi-employer defined benefit pension plans and post-retirement health and welfare plans. We participate in the Building Service 32BJ, or Union, Pension Plan and Health Plan. The Pension Plan is a multi-employer, non-contributory defined benefit pension plan that was established u... | https://www.sec.gov/Archives/edgar/data/1040971/000104097123000009/0001040971-23-000009-index.htm | 3 | true | 10-K|notes|2-5 | [
{
"fact_id": "f411eb22f8e6c4514bca5a273e0e336c6aa1c442e5dda38a443e10140cc5199d",
"concept": "us-gaap#MultiemployerPlanPensionSignificantPlanContribution",
"unit": "monetary:USD",
"period": "duration:2020-07-01..2021-06-30",
"value": "290100000",
"displayed_text": "290.1",
"text_start": 1... | [
{
"span_text": "32",
"start": 168,
"end": 170,
"class": "untagged_amount"
},
{
"span_text": "32",
"start": 428,
"end": 430,
"class": "untagged_amount"
},
{
"span_text": "13",
"start": 678,
"end": 680,
"class": "untagged_amount"
},
{
"span_text": "18793... |
039a97843a3cbacd207773a45568bb9a0b778711aa1407781d9e0031a3104a26 | 0001514991 | AMCX | AMC Networks Inc. | 4841 | 000151499125000017 | 10-Q | 2025-05-09 | 2,025 | Q1 | notes | Note 3. Net Income per Share | ables, contract assets, and contract liabilities from contracts with customers. (In thousands) March 31, 2025 December 31, 2024 Balances from contracts with customers: Accounts receivable (including long-term receivables within Other assets) $ 619,606 $ 674,631 Contract liabilities, short-term (Deferred revenue) 60,576... | Net income per basic share is based upon net income attributable to AMC Networks' stockholders divided by the weighted average number of shares of Class A Common Stock and Class B Common Stock outstanding during the period. Net income per diluted share reflects the dilutive effects, if any, of AMC Networks' outstanding... | https://www.sec.gov/Archives/edgar/data/1514991/000151499125000017/amcx-20250331.htm | 25 | true | 10-Q|notes|16-40 | [
{
"fact_id": "518b0cc46f2b7056f5a3d19c1b9b63a2a443353708cda216263b03d570200500",
"concept": "us-gaap#DebtInstrumentInterestRateStatedPercentage",
"unit": "pure",
"period": "instant:2024-06-30",
"value": "0.0425",
"displayed_text": "4.25",
"text_start": 385,
"text_end": 389,
"dime... | [
{
"span_text": "2029",
"start": 421,
"end": 425,
"class": "year"
},
{
"span_text": "2024",
"start": 467,
"end": 471,
"class": "year"
},
{
"span_text": "31,",
"start": 515,
"end": 518,
"class": "date"
},
{
"span_text": "2025",
"start": 521,
"end... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.